Amedeo Smart

Free Medical Literature Service



Colorectal Neoplasms

  Free Subscription

Articles published in
BMC Cancer
    July 2021
  1. CUBIELLA J, Gonzalez A, Almazan R, Rodriguez-Camacho E, et al
    Overtreatment in nonmalignant lesions detected in a colorectal cancer screening program: a retrospective cohort study.
    BMC Cancer. 2021;21:869.
    >> Share

  2. JIA N, Chang L, Gao X, Shi X, et al
    Association of emergence of new mutations in circulating tumuor DNA during chemotherapy with clinical outcome in metastatic colorectal cancer.
    BMC Cancer. 2021;21:845.
    >> Share

  3. WANG D, O'Rourke D, Sanchez-Garcia JF, Cai T, et al
    Development of a liquid biopsy based purely quantitative digital droplet PCR assay for detection of MLH1 promoter methylation in colorectal cancer patients.
    BMC Cancer. 2021;21:797.
    >> Share

  4. FU Y, Chen X, Song Y, Huang X, et al
    The platelet to lymphocyte ratio is a potential inflammatory marker predicting the effects of adjuvant chemotherapy in patients with stage II colorectal cancer.
    BMC Cancer. 2021;21:792.
    >> Share

  5. FU D, Ren Y, Wang C, Yu L, et al
    LINC01287 facilitates proliferation, migration, invasion and EMT of colon cancer cells via miR-4500/MAP3K13 pathway.
    BMC Cancer. 2021;21:782.
    >> Share

  6. WANG S, Pang L, Liu Z, Meng X, et al
    SERPINE1 associated with remodeling of the tumor microenvironment in colon cancer progression: a novel therapeutic target.
    BMC Cancer. 2021;21:767.
    >> Share

  7. SHANG W, Yan C, Liu R, Chen L, et al
    Clinical significance of FBXW7 tumor suppressor gene mutations and expression in human colorectal cancer: a systemic review and meta-analysis.
    BMC Cancer. 2021;21:770.
    >> Share

  8. LAMBERT P, Pitz M, Singh H, Decker K, et al
    Evaluation of algorithms using administrative health and structured electronic medical record data to determine breast and colorectal cancer recurrence in a Canadian province : Using algorithms to determine breast and colorectal cancer recurrence.
    BMC Cancer. 2021;21:763.
    >> Share

    June 2021
  9. NILSSEN Y, Eriksen MT, Guren MG, Moller B, et al
    Factors associated with emergency-onset diagnosis, time to treatment and type of treatment in colorectal cancer patients in Norway.
    BMC Cancer. 2021;21:757.
    >> Share

  10. XU H, Lan Q, Huang Y, Zhang Y, et al
    The mechanisms of colorectal cancer cell mesenchymal-epithelial transition induced by hepatocyte exosome-derived miR-203a-3p.
    BMC Cancer. 2021;21:718.
    >> Share

  11. LEE G, Jeong S, Choi S, Kim KH, et al
    Associations between alcohol consumption and cardiovascular disease among long-term survivors of colorectal cancer: a population-based, retrospective cohort study.
    BMC Cancer. 2021;21:710.
    >> Share

  12. NIEMELAINEN S, Huhtala H, Ehrlich A, Kossi J, et al
    Surgical and functional outcomes and survival following Colon Cancer surgery in the aged: a study protocol for a prospective, observational multicentre study.
    BMC Cancer. 2021;21:698.
    >> Share

  13. NAKAJIMA H, Kotani D, Bando H, Kato T, et al
    REMARRY and PURSUIT trials: liquid biopsy-guided rechallenge with anti-epidermal growth factor receptor (EGFR) therapy with panitumumab plus irinotecan for patients with plasma RAS wild-type metastatic colorectal cancer.
    BMC Cancer. 2021;21:674.
    >> Share

    May 2021
  14. HAMMAD A, Zheng ZH, Namani A, Elshaer M, et al
    Transcriptome analysis of potential candidate genes and molecular pathways in colitis-associated colorectal cancer of Mkp-1-deficient mice.
    BMC Cancer. 2021;21:607.
    >> Share

  15. TIAN P, Zhu Y, Zhang C, Guo X, et al
    Retraction Note: Ras-ERK1/2 signaling contributes to the development of colorectal cancer via regulating H3K9ac.
    BMC Cancer. 2021;21:594.
    >> Share

  16. SUSMI TF, Rahman A, Khan MMR, Yasmin F, et al
    Prognostic and clinicopathological insights of phosphodiesterase 9A gene as novel biomarker in human colorectal cancer.
    BMC Cancer. 2021;21:577.
    >> Share

  17. ADENIS A, Mazard T, Fraisse J, Chalbos P, et al
    FOLFIRINOX-R study design: a phase I/II trial of FOLFIRINOX plus regorafenib as first line therapy in patients with unresectable RAS-mutated metastatic colorectal cancer.
    BMC Cancer. 2021;21:564.
    >> Share

  18. YANG S, Bian J, George TJ, Daily K, et al
    The association between cognitive impairment and breast and colorectal cancer screening utilization.
    BMC Cancer. 2021;21:539.
    >> Share

  19. ZOK J, Bienkowski M, Radecka B, Korniluk J, et al
    Impact of relative dose intensity of oxaliplatin in adjuvant therapy among stage III colon cancer patients on early recurrence: a retrospective cohort study.
    BMC Cancer. 2021;21:529.
    >> Share

  20. IKOMA T, Shimokawa M, Kotaka M, Matsumoto T, et al
    Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan.
    BMC Cancer. 2021;21:518.
    >> Share

    April 2021
  21. LEE SHF, Abdul Rahman H, Abidin N, Ong SK, et al
    Survival of colorectal cancer patients in Brunei Darussalam: comparison between 2002-09 and 2010-17.
    BMC Cancer. 2021;21:477.
    >> Share

  22. ORTEGA-MORAN JF, Azpeitia A, Sanchez-Peralta LF, Bote-Curiel L, et al
    Medical needs related to the endoscopic technology and colonoscopy for colorectal cancer diagnosis.
    BMC Cancer. 2021;21:467.
    >> Share

  23. ENGBERSEN MP, Rijsemus CJV, Nederend J, Aalbers AGJ, et al
    Dedicated MRI staging versus surgical staging of peritoneal metastases in colorectal cancer patients considered for CRS-HIPEC; the DISCO randomized multicenter trial.
    BMC Cancer. 2021;21:464.
    >> Share

  24. DE CASTRO E GLORIA H, Jesuino Nogueira L, Bencke Grudzinski P, da Costa Ghignatti PV, et al
    Olaparib-mediated enhancement of 5-fluorouracil cytotoxicity in mismatch repair deficient colorectal cancer cells.
    BMC Cancer. 2021;21:448.
    >> Share

  25. FRENNERED A, Scherman J, Buchwald P, Johnsson A, et al
    Patterns of pathologic lymph nodes in anal cancer: a PET-CT-based analysis with implications for radiotherapy treatment volumes.
    BMC Cancer. 2021;21:447.
    >> Share

  26. PAKU M, Uemura M, Kitakaze M, Fujino S, et al
    Impact of the preoperative prognostic nutritional index as a predictor for postoperative complications after resection of locally recurrent rectal cancer.
    BMC Cancer. 2021;21:435.
    >> Share

  27. KIANI B, Hashemi Amin F, Bagheri N, Bergquist R, et al
    Association between heavy metals and colon cancer: an ecological study based on geographical information systems in North-Eastern Iran.
    BMC Cancer. 2021;21:414.
    >> Share

  28. SAKAI N, Furukawa K, Takayashiki T, Kuboki S, et al
    Differential effects of KRAS mutational status on long-term survival according to the timing of colorectal liver metastases.
    BMC Cancer. 2021;21:412.
    >> Share

  29. ZHUANG Y, Wang H, Jiang D, Li Y, et al
    Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis.
    BMC Cancer. 2021;21:380.
    >> Share

  30. VANIA L, Morris G, Ferreira E, Weiss SFT, et al
    Knock-down of LRP/LR influences signalling pathways in late-stage colorectal carcinoma cells.
    BMC Cancer. 2021;21:392.
    >> Share

  31. HUANG CC, Liu FR, Feng Q, Pan XY, et al
    Correction to: RGD4C peptide mediates anti-p21Ras scFv entry into tumor cells and produces an inhibitory effect on the human colon cancer cell line SW480.
    BMC Cancer. 2021;21:361.
    >> Share

  32. RIBEIRINHO-SOARES S, Padua D, Amaral AL, Valentini E, et al
    Prognostic significance of MUC2, CDX2 and SOX2 in stage II colorectal cancer patients.
    BMC Cancer. 2021;21:359.
    >> Share

  33. LI S, Yan G, Yue M, Wang L, et al
    Extracellular vesicles-derived microRNA-222 promotes immune escape via interacting with ATF3 to regulate AKT1 transcription in colorectal cancer.
    BMC Cancer. 2021;21:349.
    >> Share

  34. MAHMOOD RD, Shaw D, Descamps T, Zhou C, et al
    Effect of oxaliplatin plus 5-fluorouracil or capecitabine on circulating and imaging biomarkers in patients with metastatic colorectal cancer: a prospective biomarker study.
    BMC Cancer. 2021;21:354.
    >> Share

    March 2021
  35. HUANG CC, Liu FR, Feng Q, Pan XY, et al
    RGD4C peptide mediates anti-p21Ras scFv entry into tumor cells and produces an inhibitory effect on the human colon cancer cell line SW480.
    BMC Cancer. 2021;21:321.
    >> Share

  36. SHIRAISHI T, Ikeda K, Tsukada Y, Nishizawa Y, et al
    High expression of TMEM180, a novel tumour marker, is associated with poor survival in stage III colorectal cancer.
    BMC Cancer. 2021;21:302.
    >> Share

  37. LV Z, Liang Y, Liu H, Mo D, et al
    Association of chemotherapy with survival in stage II colon cancer patients who received radical surgery: a retrospective cohort study.
    BMC Cancer. 2021;21:306.
    >> Share

  38. XIAO J, Li W, Huang Y, Huang M, et al
    A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
    BMC Cancer. 2021;21:282.
    >> Share

  39. WEN C, Feng X, Yuan H, Gong Y, et al
    Circ_0003266 sponges miR-503-5p to suppress colorectal cancer progression via regulating PDCD4 expression.
    BMC Cancer. 2021;21:284.
    >> Share

  40. SATO A, Matsubayashi K, Morishima T, Nakata K, et al
    Increasing trends in the prevalence of prior cancer in newly diagnosed lung, stomach, colorectal, breast, cervical, and corpus uterine cancer patients: a population-based study.
    BMC Cancer. 2021;21:264.
    >> Share

  41. KIRITANI S, Yoshimura K, Arita J, Kokudo T, et al
    A new rapid diagnostic system with ambient mass spectrometry and machine learning for colorectal liver metastasis.
    BMC Cancer. 2021;21:262.
    >> Share

  42. CHEN J, Song Y, Li M, Zhang Y, et al
    Comprehensive analysis of ceRNA networks reveals prognostic lncRNAs related to immune infiltration in colorectal cancer.
    BMC Cancer. 2021;21:255.
    >> Share

  43. BESUTTI G, Damato A, Venturelli F, Bonelli C, et al
    Baseline liver steatosis has no impact on liver metastases and overall survival in rectal cancer patients.
    BMC Cancer. 2021;21:253.
    >> Share

  44. ZHANG M, Yang J, Jiang H, Jiang H, et al
    Correlation between glucose metabolism parameters derived from FDG and tumor TNM stages and metastasis-associated proteins in colorectal carcinoma patients.
    BMC Cancer. 2021;21:258.
    >> Share

  45. ALBUQUERQUE A, Godfrey MAL, Cappello C, Pesola F, et al
    Multizonal anogenital neoplasia in women: a cohort analysis.
    BMC Cancer. 2021;21:232.
    >> Share

  46. DROGE LH, Hennies S, Lorenzen S, Conradi LC, et al
    Prognostic value of the micronucleus assay for clinical endpoints in neoadjuvant radiochemotherapy for rectal cancer.
    BMC Cancer. 2021;21:219.
    >> Share

  47. LIN PC, Yeh YM, Chan RH, Lin BW, et al
    Sequential and co-occurring DNA damage response genetic mutations impact survival in stage III colorectal cancer patients receiving adjuvant oxaliplatin-based chemotherapy.
    BMC Cancer. 2021;21:217.
    >> Share

  48. WONG SK, Hamm J, Shokoohi A, McGahan CE, et al
    Real world duration of curative intent breast, colorectal, non-small cell lung, and prostate cancer treatment.
    BMC Cancer. 2021;21:215.
    >> Share

  49. FONSECA AS, Ramao A, Burger MC, de Souza JES, et al
    ETV4 plays a role on the primary events during the adenoma-adenocarcinoma progression in colorectal cancer.
    BMC Cancer. 2021;21:207.
    >> Share

    February 2021
  50. ARAUJO LH, Souza BM, Leite LR, Parma SAF, et al
    Molecular profile of KRAS G12C-mutant colorectal and non-small-cell lung cancer.
    BMC Cancer. 2021;21:193.
    >> Share

  51. WANG H, Gu D, Yu M, Hu Y, et al
    Variation rs9929218 and risk of the colorectal Cancer and adenomas: A meta-analysis.
    BMC Cancer. 2021;21:190.
    >> Share

  52. TAMPAKIS A, Tampaki EC, Nonni A, Kostakis ID, et al
    Correction to: High fascin-1 expression in colorectal cancer identifies patients at high risk for early disease recurrence and associated mortality.
    BMC Cancer. 2021;21:191.
    >> Share

  53. YAN L, Chen H, Tang L, Jiang P, et al
    Super-enhancer-associated long noncoding RNA AC005592.2 promotes tumor progression by regulating OLFM4 in colorectal cancer.
    BMC Cancer. 2021;21:187.
    >> Share

  54. YUAN Y, Xiao WW, Xie WH, Cai PQ, et al
    Neoadjuvant chemoradiotherapy for patients with unresectable radically locally advanced colon cancer: a potential improvement to overall survival and decrease to multivisceral resection.
    BMC Cancer. 2021;21:179.
    >> Share

  55. JIANG S, Li Q, Liu Y, Zhang H, et al
    Activation of WNT7b autocrine eases metastasis of colorectal cancer via epithelial to mesenchymal transition and predicts poor prognosis.
    BMC Cancer. 2021;21:180.
    >> Share

  56. ATHANASIOS T, Ekaterini-Christina T, Afrodite N, Ioannis KD, et al
    High fascin-1 expression in colorectal cancer identifies patients at high risk for early disease recurrence and associated mortality.
    BMC Cancer. 2021;21:153.
    >> Share

  57. MOTSUKU L, Chen WC, Muchengeti MM, Naidoo M, et al
    Colorectal cancer incidence and mortality trends by sex and population group in South Africa: 2002-2014.
    BMC Cancer. 2021;21:129.
    >> Share

  58. XI Y, Jing Z, Wei W, Chun Z, et al
    Inhibitory effect of sodium butyrate on colorectal cancer cells and construction of the related molecular network.
    BMC Cancer. 2021;21:127.
    >> Share

  59. KAWAI S, Takeshima N, Hayasaka Y, Notsu A, et al
    Comparison of irinotecan and oxaliplatin as the first-line therapies for metastatic colorectal cancer: a meta-analysis.
    BMC Cancer. 2021;21:116.
    >> Share

  60. IWAYA M, Ota H, Nakajima T, Uehara T, et al
    Most colitis associated carcinomas lack expression of LGR5: a preliminary study with implications for unique pathways of carcinogenesis compared to sporadic colorectal carcinoma.
    BMC Cancer. 2021;21:119.
    >> Share

    January 2021
  61. EL ALAMI Y, Essangri H, Majbar MA, Boutayeb S, et al
    Psychometric validation of the Moroccan version of the EORTC QLQ-C30 in colorectal Cancer patients: cross-sectional study and systematic literature review.
    BMC Cancer. 2021;21:99.
    >> Share

  62. CAO Y, Deng S, Yan L, Gu J, et al
    A nomogram based on pretreatment levels of serum bilirubin and total bile acid levels predicts survival in colorectal cancer patients.
    BMC Cancer. 2021;21:85.
    >> Share

  63. MARTINEZ-LAGO N, Fernandez-Montes A, Covela M, Brozos EM, et al
    Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain.
    BMC Cancer. 2021;21:64.
    >> Share

  64. XU Y, Li C, Zheng CZ, Zhang YQ, et al
    Comparison of long-term outcomes between Lynch sydrome and sporadic colorectal cancer: a propensity score matching analysis.
    BMC Cancer. 2021;21:45.
    >> Share

  65. ZHOU S, Feng Q, Zhang J, Zhou H, et al
    High-grade postoperative complications affect survival outcomes of patients with colorectal Cancer peritoneal metastases treated with Cytoreductive surgery and Hyperthermic Intraperitoneal chemotherapy.
    BMC Cancer. 2021;21:41.
    >> Share

  66. HUANG C, Gu X, Zeng X, Chen B, et al
    Cetuximab versus bevacizumab following prior FOLFOXIRI and bevacizumab in postmenopausal women with advanced KRAS and BRAF wild-type colorectal cancer: a retrospective study.
    BMC Cancer. 2021;21:30.
    >> Share

  67. CHEN X, Wu H, Feng J, Li Y, et al
    Transcriptome profiling unveils GAP43 regulates ABC transporters and EIF2 signaling in colorectal cancer cells.
    BMC Cancer. 2021;21:24.
    >> Share

  68. MIWA K, Oki E, Enomoto M, Ihara K, et al
    Randomized phase II study comparing the efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer (KSCC1301).
    BMC Cancer. 2021;21:23.
    >> Share

  69. CONG J, Gong J, Yang C, Xia Z, et al
    MiR-200c/FUT4 axis prevents the proliferation of colon cancer cells by downregulating the Wnt/beta-catenin pathway.
    BMC Cancer. 2021;21:2.
    >> Share

    December 2020
  70. MOON B, Yang SJ, Park SM, Lee SH, et al
    LAD1 expression is associated with the metastatic potential of colorectal cancer cells.
    BMC Cancer. 2020;20:1180.
    >> Share

    November 2020
  71. ARNOLD A, Tronser M, Sers C, Ahadova A, et al
    Correction to: The majority of beta-catenin mutations in colorectal cancer is homozygous.
    BMC Cancer. 2020;20:1151.
    >> Share

  72. RUMPOLD H, Niedersuss-Beke D, Heiler C, Falch D, et al
    Prediction of mortality in metastatic colorectal cancer in a real-life population: a multicenter explorative analysis.
    BMC Cancer. 2020;20:1149.
    >> Share

  73. ZHANG Z, Zheng S, Lin Y, Sun J, et al
    Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients.
    BMC Cancer. 2020;20:1135.
    >> Share

  74. SATAKE H, Ando K, Oki E, Shimokawa M, et al
    Protocol of the EFFORT study: a prospective study of FOLFIRI plus aflibercept as second-line treatment after progression on FOLFOXIRI plus bevacizumab or during maintenance treatment in patients with unresectable/metastatic colorectal cancer.
    BMC Cancer. 2020;20:1116.
    >> Share

  75. CAO Y, Gu J, Yan L, Deng S, et al
    The value of haematological parameters and serum tumour markers for predicting KRAS mutations in 784 Chinese colorectal cancer patients: a retrospective analysis.
    BMC Cancer. 2020;20:1099.
    >> Share

  76. TAKAMIZAWA Y, Shida D, Boku N, Nakamura Y, et al
    Nutritional and inflammatory measures predict survival of patients with stage IV colorectal cancer.
    BMC Cancer. 2020;20:1092.
    >> Share

  77. GRIGORE B, Lewis R, Peters J, Robinson S, et al
    Development, validation and effectiveness of diagnostic prediction tools for colorectal cancer in primary care: a systematic review.
    BMC Cancer. 2020;20:1084.
    >> Share

  78. BARBIROU M, Woldu HG, Sghaier I, Bedoui SA, et al
    Western influenced lifestyle and Kv2.1 association as predicted biomarkers for Tunisian colorectal cancer.
    BMC Cancer. 2020;20:1086.
    >> Share

  79. HOYDAHL O, Edna TH, Xanthoulis A, Lydersen S, et al
    Long-term trends in colorectal cancer: incidence, localization, and presentation.
    BMC Cancer. 2020;20:1077.
    >> Share

  80. ZENG C, Xiong D, Cheng F, Luo Q, et al
    Retrospective analysis of LNM risk factors and the effect of chemotherapy in early colorectal cancer: A Chinese multicenter study.
    BMC Cancer. 2020;20:1067.
    >> Share

    October 2020
  81. ARNOLD A, Tronser M, Sers C, Ahadova A, et al
    The majority of beta-catenin mutations in colorectal cancer is homozygous.
    BMC Cancer. 2020;20:1038.
    >> Share

  82. DAU H, Safari A, Saad El Din K, McTaggart-Cowan H, et al
    Assessing how health information needs of individuals with colorectal cancer are met across the care continuum: an international cross-sectional survey.
    BMC Cancer. 2020;20:1031.
    >> Share

  83. JIANG Y, Yan X, Liu K, Shi Y, et al
    Discovering the molecular differences between right- and left-sided colon cancer using machine learning methods.
    BMC Cancer. 2020;20:1012.
    >> Share

  84. XU X, Yu Y, Shen M, Liu M, et al
    Role of circulating free DNA in evaluating clinical tumor burden and predicting survival in Chinese metastatic colorectal cancer patients.
    BMC Cancer. 2020;20:1006.
    >> Share

  85. PENG Q, Shen Y, Zhao P, Cai S, et al
    Biomarker exploration of microRNA-203 as a promising substrate for predicting poor survival outcome in colorectal cancer.
    BMC Cancer. 2020;20:1003.
    >> Share

  86. PENG Z, Hou X, Huang Y, Xie T, et al
    Cost-effectiveness analysis of fruquintinib for metastatic colorectal cancer third-line treatment in China.
    BMC Cancer. 2020;20:990.
    >> Share

  87. JIN LP, Liu T, Meng FQ, Tai JD, et al
    Prognosis prediction model based on competing endogenous RNAs for recurrence of colon adenocarcinoma.
    BMC Cancer. 2020;20:968.
    >> Share

  88. KENNEDY SA, Morrissey ME, Dunne MR, O'Connell F, et al
    Combining 1,4-dihydroxy quininib with Bevacizumab/FOLFOX alters angiogenic and inflammatory secretions in ex vivo colorectal tumors.
    BMC Cancer. 2020;20:952.
    >> Share

  89. KIM N, Yoon HI, Kim JS, Koom WS, et al
    Simple calculation using anatomical features on pre-treatment verification CT for bladder volume estimation during radiation therapy for rectal cancer.
    BMC Cancer. 2020;20:942.
    >> Share

    September 2020
  90. MAZAKI J, Katsumata K, Kasahara K, Tago T, et al
    Neutrophil-to-lymphocyte ratio is a prognostic factor for colon cancer: a propensity score analysis.
    BMC Cancer. 2020;20:922.
    >> Share

  91. CHEN H, Luo J, Guo J
    Identification of an alternative splicing signature as an independent factor in colon cancer.
    BMC Cancer. 2020;20:904.
    >> Share

  92. YOO E, Lee J, Lertpatipanpong P, Ryu J, et al
    Anti-proliferative activity of A. Oxyphylla and its bioactive constituent nootkatone in colorectal cancer cells.
    BMC Cancer. 2020;20:881.
    >> Share

  93. DAVIS JS, Kanikarla-Marie P, Gagea M, Yu PL, et al
    Sulindac plus a phospholipid is effective for polyp reduction and safer than sulindac alone in a mouse model of colorectal cancer development.
    BMC Cancer. 2020;20:871.
    >> Share

  94. FENG X, Wei G, Wang W, Zhang Y, et al
    Nomogram for individually predicting overall survival in rectal neuroendocrine tumours.
    BMC Cancer. 2020;20:865.
    >> Share

  95. FENG Y, Peng C, Zhu Y, Liu L, et al
    Biplane transrectal ultrasonography plus ultrasonic elastosonography and contrast-enhanced ultrasonography in T staging of rectal cancer.
    BMC Cancer. 2020;20:862.
    >> Share

  96. ZHANG Y, Yan L, Wu Y, Xu M, et al
    Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer.
    BMC Cancer. 2020;20:854.
    >> Share

  97. COEBERGH VAN DEN BRAAK RRJ, Ten Hoorn S, Sieuwerts AM, Tuynman JB, et al
    Interconnectivity between molecular subtypes and tumor stage in colorectal cancer.
    BMC Cancer. 2020;20:850.
    >> Share

  98. OKUYAMA T, Sameshima S, Takeshita E, Mitsui T, et al
    Myxoid stroma is associated with postoperative relapse in patients with stage II colon cancer.
    BMC Cancer. 2020;20:842.
    >> Share

  99. AL-KHAYAL K, Vaali-Mohammed MA, Elwatidy M, Traiki TB, et al
    Correction to: A novel coordination complex of platinum (PT) induces cell death in colorectal cancer by altering redox balance and modulating MAPK pathway.
    BMC Cancer. 2020;20:834.
    >> Share

  100. SHAMSEDDINE A, Zeidan YH, Kreidieh M, Khalifeh I, et al
    Short-course radiation followed by mFOLFOX-6 plus avelumab for locally-advanced rectal adenocarcinoma.
    BMC Cancer. 2020;20:831.
    >> Share

    August 2020
  101. DAMATO A, Iachetta F, Antonuzzo L, Nasti G, et al
    Phase II study on first-line treatment of NIVolumab in combination with folfoxiri/bevacizumab in patients with Advanced COloRectal cancer RAS or BRAF mutated - NIVACOR trial (GOIRC-03-2018).
    BMC Cancer. 2020;20:822.
    >> Share

  102. TABUNG FK, Noonan A, Lee DH, Song M, et al
    Post-diagnosis dietary insulinemic potential and survival outcomes among colorectal cancer patients.
    BMC Cancer. 2020;20:817.
    >> Share

  103. SCHRAA SJ, van Rooijen KL, van der Kruijssen DEW, Rubio Alarcon C, et al
    Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study.
    BMC Cancer. 2020;20:790.
    >> Share

  104. ARTUS A, Tabchouri N, Iskander O, Michot N, et al
    Long term outcome of anastomotic leakage in patients undergoing low anterior resection for rectal cancer.
    BMC Cancer. 2020;20:780.
    >> Share

  105. VAN DEN BERG I, van de Weerd S, Roodhart JML, Vink GR, et al
    Improving clinical management of colon cancer through CONNECTION, a nation-wide colon cancer registry and stratification effort (CONNECTION II trial): rationale and protocol of a single arm intervention study.
    BMC Cancer. 2020;20:776.
    >> Share

  106. WANG Q, Ye F, Ma P, Che Y, et al
    Quantified MRI and 25OH-VitD3 can be used as effective biomarkers for patients with neoadjuvant chemotherapy-induced liver injury in CRCLM?
    BMC Cancer. 2020;20:767.
    >> Share

  107. BAQAR AR, Wilkins S, Wang W, Oliva K, et al
    Log odds of positive lymph nodes is prognostically equivalent to lymph node ratio in non-metastatic colon cancer.
    BMC Cancer. 2020;20:762.
    >> Share

  108. SARASQUETA C, Zunzunegui MV, Enriquez Navascues JM, Querejeta A, et al
    Gender differences in stage at diagnosis and preoperative radiotherapy in patients with rectal cancer.
    BMC Cancer. 2020;20:759.
    >> Share

  109. YANG H, Yao Z, Cui M, Xing J, et al
    Influence of tumor location on short- and long-term outcomes after laparoscopic surgery for rectal cancer: a propensity score matched cohort study.
    BMC Cancer. 2020;20:761.
    >> Share

  110. SHADMANI FK, Farzadfar F, Yoosefi M, Mansori K, et al
    Premature mortality of gastrointestinal cancer in Iran: trends and projections 2001-2030.
    BMC Cancer. 2020;20:752.
    >> Share

  111. SCHOTTKER B, Kuznia S, Laetsch DC, Czock D, et al
    Protocol of the VICTORIA study: personalized vitamin D supplementation for reducing or preventing fatigue and enhancing quality of life of patients with colorectal tumor - randomized intervention trial.
    BMC Cancer. 2020;20:739.
    >> Share

    July 2020
  112. HECKL SM, Pellinghaus M, Behrens HM, Kruger S, et al
    Questioning the IGF1 receptor's assigned role in CRC - a case for rehabilitation?
    BMC Cancer. 2020;20:704.
    >> Share

  113. EL ASRI A, Zarrouq B, El Kinany K, Bouguenouch L, et al
    Associations between nutritional factors and KRAS mutations in colorectal cancer: a systematic review.
    BMC Cancer. 2020;20:696.
    >> Share

  114. ONWUKA JU, Li D, Liu Y, Huang H, et al
    A panel of DNA methylation signature from peripheral blood may predict colorectal cancer susceptibility.
    BMC Cancer. 2020;20:692.
    >> Share

  115. MIYO M, Kato T, Yoshino T, Yamanaka T, et al
    Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer.
    BMC Cancer. 2020;20:687.
    >> Share

  116. AL-KHAYAL K, Vaali-Mohammed MA, Elwatidy M, Bin Traiki T, et al
    A novel coordination complex of platinum (PT) induces cell death in colorectal cancer by altering redox balance and modulating MAPK pathway.
    BMC Cancer. 2020;20:685.
    >> Share

  117. ANTONIOTTI C, Borelli B, Rossini D, Pietrantonio F, et al
    AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer.
    BMC Cancer. 2020;20:683.
    >> Share

  118. LU Y, Wang X, Li P, Zhang T, et al
    Clinical characteristics and prognosis of anal squamous cell carcinoma: a retrospective audit of 144 patients from 11 cancer hospitals in southern China.
    BMC Cancer. 2020;20:679.
    >> Share

  119. DE LACY FB, Roodbeen SX, Rios J, van Laarhoven J, et al
    Three-year outcome after transanal versus laparoscopic total mesorectal excision in locally advanced rectal cancer: a multicenter comparative analysis.
    BMC Cancer. 2020;20:677.
    >> Share

  120. HU F, Wang Q, Yang Z, Zhang Z, et al
    Network-based identification of biomarkers for colon adenocarcinoma.
    BMC Cancer. 2020;20:668.
    >> Share

  121. YANG SY, Kim MJ, Kye BH, Han YD, et al
    Prospective study of oncologic outcomes after laparoscopic modified complete mesocolic excision for non-metastatic right colon cancer (PIONEER study): study protocol of a multicentre single-arm trial.
    BMC Cancer. 2020;20:657.
    >> Share

  122. LIN JL, Lin JX, Zheng CH, Li P, et al
    Relationship between aspirin use of esophageal, gastric and colorectal cancer patient survival: a meta-analysis.
    BMC Cancer. 2020;20:638.
    >> Share

  123. WRIGHT CM, Halkett G, Carey Smith R, Moorin R, et al
    Sarcoma epidemiology and cancer-related hospitalisation in Western Australia from 1982 to 2016: a descriptive study using linked administrative data.
    BMC Cancer. 2020;20:625.
    >> Share

  124. RUHNAU J, Parczyk J, Danker K, Eickholt B, et al
    Synergisms of genome and metabolism stabilizing antitumor therapy (GMSAT) in human breast and colon cancer cell lines: a novel approach to screen for synergism.
    BMC Cancer. 2020;20:617.
    >> Share

  125. GUTIERREZ-STAMPA MA, Aguilar V, Sarasqueta C, Cubiella J, et al
    Impact of the faecal immunochemical test on colorectal cancer survival.
    BMC Cancer. 2020;20:616.
    >> Share

    June 2020
  126. KUO IM, Lee JJ, Wang YS, Chiang HC, et al
    Potential enhancement of host immunity and anti-tumor efficacy of nanoscale curcumin and resveratrol in colorectal cancers by modulated electro- hyperthermia.
    BMC Cancer. 2020;20:603.
    >> Share

  127. MOSKOWITZ JE, Doran AG, Lei Z, Busi SB, et al
    Integration of genomics, metagenomics, and metabolomics to identify interplay between susceptibility alleles and microbiota in adenoma initiation.
    BMC Cancer. 2020;20:600.
    >> Share

  128. TANG CT, Zeng L, Yang J, Zeng C, et al
    Nomograms that predict the survival of patients with adenocarcinoma in villous adenoma of the colorectum: a SEER-based study.
    BMC Cancer. 2020;20:608.
    >> Share

  129. ALTUNEL E, Roghani RS, Chen KY, Kim SY, et al
    Development of a precision medicine pipeline to identify personalized treatments for colorectal cancer.
    BMC Cancer. 2020;20:592.
    >> Share

  130. YANG X, Wu W, Pan Y, Zhou Q, et al
    Immune-related genes in tumor-specific CD4(+) and CD8(+) T cells in colon cancer.
    BMC Cancer. 2020;20:585.
    >> Share

  131. YANG X, Zheng E, Ye L, Gu C, et al
    The effect of pericolic lymph nodes metastasis beyond 10 cm proximal to the tumor on patients with rectal cancer.
    BMC Cancer. 2020;20:573.
    >> Share

  132. DESHAYES E, Piron L, Bouvier A, Lapuyade B, et al
    Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatect
    BMC Cancer. 2020;20:574.
    >> Share

  133. PARAKRAMA R, Fogel E, Chandy C, Augustine T, et al
    Immune characterization of metastatic colorectal cancer patients post reovirus administration.
    BMC Cancer. 2020;20:569.
    >> Share

  134. MORRISSEY ME, Byrne R, Nulty C, McCabe NH, et al
    The tumour microenvironment of the upper and lower gastrointestinal tract differentially influences dendritic cell maturation.
    BMC Cancer. 2020;20:566.
    >> Share

  135. NEGARANDEH R, Salehifar E, Saghafi F, Jalali H, et al
    Evaluation of adverse effects of chemotherapy regimens of 5-fluoropyrimidines derivatives and their association with DPYD polymorphisms in colorectal cancer patients.
    BMC Cancer. 2020;20:560.
    >> Share

  136. ITO M, Kodaira T, Koide Y, Okuda T, et al
    Role of high-dose salvage radiotherapy for oligometastases of the localised abdominal/pelvic lymph nodes: a retrospective study.
    BMC Cancer. 2020;20:540.
    >> Share

  137. MEHLIS K, Witte J, Surmann B, Kudlich M, et al
    The patient-level effect of the cost of Cancer care - financial burden in German Cancer patients.
    BMC Cancer. 2020;20:529.
    >> Share

  138. PENG Q, Shen Y, Zhao P, Cheng M, et al
    Biomarker roles identification of miR-106 family for predicting the risk and poor survival of colorectal cancer.
    BMC Cancer. 2020;20:506.
    >> Share

  139. CHANG H, Tao YL, Jiang W, Chen C, et al
    Optimize the dose of oxaliplatin for locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy followed by radical surgery and adjuvant chemotherapy.
    BMC Cancer. 2020;20:498.
    >> Share

    May 2020
  140. NILSSEN Y, Brustugun OT, Eriksen MT, Haug ES, et al
    Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016.
    BMC Cancer. 2020;20:488.
    >> Share

  141. BROUQUET A, Bachet JB, Huguet F, Karoui M, et al
    NORAD01-GRECCAR16 multicenter phase III non-inferiority randomized trial comparing preoperative modified FOLFIRINOX without irradiation to radiochemotherapy for resectable locally advanced rectal cancer (intergroup FRENCH-GRECCAR- PRODIGE trial).
    BMC Cancer. 2020;20:485.
    >> Share

  142. ZHU XD, Wang J, You QH, Jiang TA, et al
    An isolated vaginal metastasis from intestinal signet ring cell carcinoma: a case report and literature review.
    BMC Cancer. 2020;20:478.
    >> Share

  143. MAHAR AL, Kurdyak P, Hanna TP, Coburn NG, et al
    Cancer staging in individuals with a severe psychiatric illness: a cross-sectional study using population-based cancer registry data.
    BMC Cancer. 2020;20:476.
    >> Share

  144. BUCKSCH K, Zachariae S, Aretz S, Buttner R, et al
    Cancer risks in Lynch syndrome, Lynch-like syndrome, and familial colorectal cancer type X: a prospective cohort study.
    BMC Cancer. 2020;20:460.
    >> Share

  145. YUAN J, Guo D, Li X, Chen J, et al
    Prognostic and diagnostic value of circRNA expression in colorectal carcinoma: a meta-analysis.
    BMC Cancer. 2020;20:448.
    >> Share

  146. SUN Y, Cao B, Zhou J
    Roles of DANCR/microRNA-518a-3p/MDMA ceRNA network in the growth and malignant behaviors of colon cancer cells.
    BMC Cancer. 2020;20:434.
    >> Share

  147. EYL RE, Thong MSY, Carr PR, Jansen L, et al
    Physical activity and long-term fatigue among colorectal cancer survivors - a population-based prospective study.
    BMC Cancer. 2020;20:438.
    >> Share

  148. DAVIDSEN J, Jessen SB, Watt SK, Larsen S, et al
    CDX2 expression and perioperative patient serum affects the adhesion properties of cultured colon cancer cells.
    BMC Cancer. 2020;20:426.
    >> Share

  149. ZHANG H, Yuan L, Liu L, Yan C, et al
    Dynamic alterations of genome and transcriptome in KRAS G13D mutant CRC PDX model treated with cetuximab.
    BMC Cancer. 2020;20:416.
    >> Share

  150. SALIMZADEH H, Lindskog EB, Gustavsson B, Wettergren Y, et al
    Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival.
    BMC Cancer. 2020;20:409.
    >> Share

  151. TSUKUI H, Horie H, Koinuma K, Ohzawa H, et al
    CD73 blockade enhances the local and abscopal effects of radiotherapy in a murine rectal cancer model.
    BMC Cancer. 2020;20:411.
    >> Share

  152. LI X, Sun K, Liao X, Gao H, et al
    Colorectal carcinomas with mucinous differentiation are associated with high frequent mutation of KRAS or BRAF mutations, irrespective of quantity of mucinous component.
    BMC Cancer. 2020;20:400.
    >> Share

  153. CHEN H, Luo J, Guo J
    Development and validation of a five-immune gene prognostic risk model in colon cancer.
    BMC Cancer. 2020;20:395.
    >> Share

  154. CALCATERRA SL, Burnett-Hartman AN, Powers JD, Corley DA, et al
    A population-based survey to assess the association between cannabis and quality of life among colorectal cancer survivors.
    BMC Cancer. 2020;20:373.
    >> Share

  155. PARK JH, Lee DH, Kim SI, Kim NK, et al
    Moderate to vigorous physical activity participation associated with better quality of life among breast and colorectal cancer survivors in Korea.
    BMC Cancer. 2020;20:365.
    >> Share

    April 2020
  156. WU P, Zhou Q, Zhu H, Zhuang Y, et al
    Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
    BMC Cancer. 2020;20:354.
    >> Share

  157. KITAGAWA Y, Osumi H, Shinozaki E, Ota Y, et al
    Clinical utility of polyethylene glycol conjugated granulocyte colony-stimulating factor (PEG-G-CSF) for preventing severe neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI plus bevacizumab: a single-center retrospective stud
    BMC Cancer. 2020;20:358.
    >> Share

  158. ERFANI M, Hosseini SV, Mokhtari M, Zamani M, et al
    Altered ARID1A expression in colorectal cancer.
    BMC Cancer. 2020;20:350.
    >> Share

  159. KIM S, Buecher B, Andre T, Jary M, et al
    Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trial.
    BMC Cancer. 2020;20:352.
    >> Share

  160. THERKILDSEN C, Rasmussen M, Smith-Hansen L, Kallemose T, et al
    Broadening risk profile in familial colorectal cancer type X; increased risk for five cancer types in the national Danish cohort.
    BMC Cancer. 2020;20:345.
    >> Share

  161. NAKAJIMA T, Uehara T, Iwaya M, Kobayashi Y, et al
    Characterization of LGR5 expression in poorly differentiated colorectal carcinoma with mismatch repair protein deficiency.
    BMC Cancer. 2020;20:319.
    >> Share

  162. LI X, Yu W, Liang C, Xu Y, et al
    INHBA is a prognostic predictor for patients with colon adenocarcinoma.
    BMC Cancer. 2020;20:305.
    >> Share

  163. MUKUND K, Syulyukina N, Ramamoorthy S, Subramaniam S, et al
    Right and left-sided colon cancers - specificity of molecular mechanisms in tumorigenesis and progression.
    BMC Cancer. 2020;20:317.
    >> Share

  164. STEEGHS EMP, Kroeze LI, Tops BBJ, van Kempen LC, et al
    Comprehensive routine diagnostic screening to identify predictive mutations, gene amplifications, and microsatellite instability in FFPE tumor material.
    BMC Cancer. 2020;20:291.
    >> Share

  165. EL DIN KS, Loree JM, Sayre EC, Gill S, et al
    Trends in the epidemiology of young-onset colorectal cancer: a worldwide systematic review.
    BMC Cancer. 2020;20:288.
    >> Share

  166. ORJUELA S, Menigatti M, Schraml P, Kambakamba P, et al
    The DNA hypermethylation phenotype of colorectal cancer liver metastases resembles that of the primary colorectal cancers.
    BMC Cancer. 2020;20:290.
    >> Share

    March 2020
  167. KOSARI F, Taheri M, Moradi A, Hakimi Alni R, et al
    Evaluation of cinnamon extract effects on clbB gene expression and biofilm formation in Escherichia coli strains isolated from colon cancer patients.
    BMC Cancer. 2020;20:267.
    >> Share

  168. WATANABE K, Katayama K, Yoshioka T, Narimatsu H, et al
    Impact of individual background on the unmet needs of cancer survivors and caregivers - a mixed-methods analysis.
    BMC Cancer. 2020;20:263.
    >> Share

  169. CAI Z, Xie X, Chen Y, Chen Z, et al
    Risk factor analysis for inaccurate pre-operative MRI staging in rectal cancer.
    BMC Cancer. 2020;20:253.
    >> Share

  170. SCHLIEMANN D, Paramasivam D, Dahlui M, Cardwell CR, et al
    Change in public awareness of colorectal cancer symptoms following the Be Cancer Alert Campaign in the multi-ethnic population of Malaysia.
    BMC Cancer. 2020;20:252.
    >> Share

  171. SIEBENHUNER AR, Guller U, Warschkow R
    Population-based SEER analysis of survival in colorectal cancer patients with or without resection of lung and liver metastases.
    BMC Cancer. 2020;20:246.
    >> Share

  172. ZHOU F, Tang D, Xu Y, He H, et al
    Identification of microRNAs and their Endonucleolytic Cleavaged target mRNAs in colorectal cancer.
    BMC Cancer. 2020;20:242.
    >> Share

  173. JIN XH, Lu S, Wang AF
    Expression and clinical significance of miR-4516 and miR-21-5p in serum of patients with colorectal cancer.
    BMC Cancer. 2020;20:241.
    >> Share

  174. LYHNE JD, Smith A'B, Frostholm L, Fink P, et al
    Study protocol: a randomized controlled trial comparing the efficacy of therapist guided internet-delivered cognitive therapy (TG-iConquerFear) with augmented treatment as usual in reducing fear of cancer recurrence in Danish colorectal cancer survivo
    BMC Cancer. 2020;20:223.
    >> Share

  175. LI J, Xu X, Jiang Y, Hansbro NG, et al
    Elastin is a key factor of tumor development in colorectal cancer.
    BMC Cancer. 2020;20:217.
    >> Share

  176. XIA LJ, Li W, Zhai JC, Yan CW, et al
    Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and prognostic nutritional index for predicting clinical outcomes in T1-2 rectal cancer.
    BMC Cancer. 2020;20:208.
    >> Share

  177. PAOLISSO P, Saturi G, Foa A, Saponara M, et al
    Primary malignant pericardial tumour in Lynch syndrome.
    BMC Cancer. 2020;20:191.
    >> Share

    February 2020
  178. KOWALCZYK M, Orlowski M, Klepacki L, Zinkiewicz K, et al
    Rectal aberrant crypt foci (ACF) as a predictor of benign and malignant neoplastic lesions in the large intestine.
    BMC Cancer. 2020;20:133.
    >> Share

  179. XU R, Wang W, Zhu B, Lin X, et al
    Disease characteristics and treatment patterns of Chinese patients with metastatic colorectal cancer: a retrospective study using medical records from China.
    BMC Cancer. 2020;20:131.
    >> Share

  180. MIELE E, Abballe L, Spinelli GP, Besharat ZM, et al
    BRAF mutant colorectal cancer: ErbB2 expression levels as predictive factor for the response to combined BRAF/ErbB inhibitors.
    BMC Cancer. 2020;20:129.
    >> Share

  181. SHEN Y, Guan Y, Hummel JJ, Shyu CR, et al
    Immunogenomic pathways associated with cytotoxic lymphocyte infiltration and survival in colorectal cancer.
    BMC Cancer. 2020;20:124.
    >> Share

  182. PRESTON JL, Stiffler N
    Epigenetic loss of heterozygosity of Apc and an inflammation-associated mutational signature detected in Lrig1(+/-)-driven murine colonic adenomas.
    BMC Cancer. 2020;20:126.
    >> Share

  183. PERROTT S, Laurie K, Laws K, Johnes A, et al
    Young-onset colorectal cancer in the North East of Scotland: survival, clinico-pathological features and genetics.
    BMC Cancer. 2020;20:108.
    >> Share

  184. NOWAK RG, Nnaji CH, Dauda W, Mitchell A, et al
    Satisfaction with high-resolution anoscopy for anal cancer screening among men who have sex with men: a cross-sectional survey in Abuja, Nigeria.
    BMC Cancer. 2020;20:98.
    >> Share

  185. CHEN F, Qu M, Zhang F, Tan Z, et al
    IL-36 s in the colorectal cancer: is interleukin 36 good or bad for the development of colorectal cancer?
    BMC Cancer. 2020;20:92.
    >> Share

  186. IVESON T, Carter AM, Shiu KK, Spooner C, et al
    Review of metastatic colorectal cancer treatment pathways and early clinical experience of trifluridine/tipiracil in the UK named patient programme.
    BMC Cancer. 2020;20:91.
    >> Share

    January 2020
  187. MANOHARAN V, Karunanayake EH, Tennekoon KH, De Silva S, et al
    Pattern of nucleotide variants of TP53 and their correlation with the expression of p53 and its downstream proteins in a Sri Lankan cohort of breast and colorectal cancer patients.
    BMC Cancer. 2020;20:72.
    >> Share

  188. BOILEVE A, Maillard A, Wagner M, Dromain C, et al
    Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy - a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)-
    BMC Cancer. 2020;20:74.
    >> Share

  189. HAN JG, Wang ZJ, Zeng WG, Wang YB, et al
    Efficacy and safety of self-expanding metallic stent placement followed by neoadjuvant chemotherapy and scheduled surgery for treatment of obstructing left-sided colonic cancer.
    BMC Cancer. 2020;20:57.
    >> Share

  190. NOH BJ, Kwak JY, Eom DW
    Immune classification for the PD-L1 expression and tumour-infiltrating lymphocytes in colorectal adenocarcinoma.
    BMC Cancer. 2020;20:58.
    >> Share

  191. FOWLER H, Belot A, Ellis L, Maringe C, et al
    Comorbidity prevalence among cancer patients: a population-based cohort study of four cancers.
    BMC Cancer. 2020;20:2.
    >> Share

  192. ARIANS N, Hafner M, Krisam J, Lang K, et al
    Intrafractional vaginal dilation in anal cancer patients undergoing pelvic radiotherapy (DILANA) - a prospective, randomized, 2-armed phase-II-trial.
    BMC Cancer. 2020;20:52.
    >> Share

  193. SIGNAL V, Jackson C, Signal L, Hardie C, et al
    Improving management of comorbidity in patients with colorectal cancer using comprehensive medical assessment: a pilot study.
    BMC Cancer. 2020;20:50.
    >> Share

  194. LICHTHARDT S, Wagner J, Lob S, Matthes N, et al
    Pathological complete response due to a prolonged time interval between preoperative chemoradiation and surgery in locally advanced rectal cancer: analysis from the German StuDoQ|Rectalcarcinoma registry.
    BMC Cancer. 2020;20:49.
    >> Share

  195. KOHOUTOVA D, Forstlova M, Moravkova P, Cyrany J, et al
    Bacteriocin production by mucosal bacteria in current and previous colorectal neoplasia.
    BMC Cancer. 2020;20:39.
    >> Share

  196. WANG Q, Wang Z, Wu Y, Klinke DJ 2nd, et al
    An in silico exploration of combining Interleukin-12 with Oxaliplatin to treat liver-metastatic colorectal cancer.
    BMC Cancer. 2020;20:26.
    >> Share

  197. KAWAMURA H, Morishima T, Sato A, Honda M, et al
    Effect of adjuvant chemotherapy on survival benefit in stage III colon cancer patients stratified by age: a Japanese real-world cohort study.
    BMC Cancer. 2020;20:19.
    >> Share

  198. QADERI SM, Wijffels NAT, Bremers AJA, de Wilt JHW, et al
    Major differences in follow-up practice of patients with colorectal cancer; results of a national survey in the Netherlands.
    BMC Cancer. 2020;20:22.
    >> Share

    December 2019
  199. WANG X, Yu Q, Ghareeb WM, Zhang Y, et al
    Downregulated SPINK4 is associated with poor survival in colorectal cancer.
    BMC Cancer. 2019;19:1258.
    >> Share

  200. ZHANG X, Sun H, Chen W, He X, et al
    Elevated expression of AGGF1 predicts poor prognosis and promotes the metastasis of colorectal cancer.
    BMC Cancer. 2019;19:1252.
    >> Share

  201. KOTANI D, Kuboki Y, Horasawa S, Kaneko A, et al
    Retrospective cohort study of trifluridine/tipiracil (TAS-102) plus bevacizumab versus trifluridine/tipiracil monotherapy for metastatic colorectal cancer.
    BMC Cancer. 2019;19:1253.
    >> Share

  202. SASTRE D, Baiochi J, de Souza Lima IM, Canto de Souza F, et al
    Focused screening reveals functional effects of microRNAs differentially expressed in colorectal cancer.
    BMC Cancer. 2019;19:1239.
    >> Share

  203. SONG N, Lee J, Cho S, Kim J, et al
    Evaluation of gene-environment interactions for colorectal cancer susceptibility loci using case-only and case-control designs.
    BMC Cancer. 2019;19:1231.
    >> Share

  204. ZHANG X, Browman G, Siu W, Basen-Engquist KM, et al
    The BE GONE trial study protocol: a randomized crossover dietary intervention of dry beans targeting the gut microbiome of overweight and obese patients with a history of colorectal polyps or cancer.
    BMC Cancer. 2019;19:1233.
    >> Share

  205. LIU X, Fu J, Bi H, Ge A, et al
    DNA methylation of SFRP1, SFRP2, and WIF1 and prognosis of postoperative colorectal cancer patients.
    BMC Cancer. 2019;19:1212.
    >> Share

  206. JANG YC, Huang HL, Leung CY
    Association of hormone replacement therapy with mortality in colorectal cancer survivor: a systematic review and meta-analysis.
    BMC Cancer. 2019;19:1199.
    >> Share

  207. SHANG L, Fang Z, Liu J, Du F, et al
    Case report of ascending colon cancer and multiple jejunal GISTs in a patient with neurofibromatosis type 1 (NF1).
    BMC Cancer. 2019;19:1196.
    >> Share

  208. MANCEAU G, Brouquet A, Chaibi P, Passot G, et al
    Multicenter phase III randomized trial comparing laparoscopy and laparotomy for colon cancer surgery in patients older than 75 years: the CELL study, a Federation de Recherche en Chirurgie (FRENCH) trial.
    BMC Cancer. 2019;19:1185.
    >> Share

  209. WEBER S, Koschade SE, Hoffmann CM, Dubash TD, et al
    The notch target gene HEYL modulates metastasis forming capacity of colorectal cancer patient-derived spheroid cells in vivo.
    BMC Cancer. 2019;19:1181.
    >> Share

    November 2019
  210. PURCELL RV, Schmeier S, Lau YC, Pearson JF, et al
    Molecular subtyping improves prognostication of Stage 2 colorectal cancer.
    BMC Cancer. 2019;19:1155.
    >> Share

  211. GARCIA-GARCIA T, Carmona-Bayonas A, Jimenez-Fonseca P, Jara C, et al
    Biopsychosocial and clinical characteristics in patients with resected breast and colon cancer at the beginning and end of adjuvant treatment.
    BMC Cancer. 2019;19:1143.
    >> Share

  212. WANG HE, Liao YC, Hu JM, Wu WC, et al
    Correlation between kidney transplantation and colorectal cancer in hemodialysis patients: A nationwide, retrospective, population-based cohort study.
    BMC Cancer. 2019;19:1120.
    >> Share

  213. CALAPRE L, Warburton L, Millward M, Gray ES, et al
    Circulating tumour DNA (ctDNA) as a biomarker in metachronous melanoma and colorectal cancer- a case report.
    BMC Cancer. 2019;19:1109.
    >> Share

  214. XU Y, Xu Q, Ma Y, Duan J, et al
    Characterizing MRI features of rectal cancers with different KRAS status.
    BMC Cancer. 2019;19:1111.
    >> Share

  215. MUSSELWHITE LW, Redding TS 4th, Sims KJ, O'Leary MC, et al
    Advanced neoplasia in Veterans at screening colonoscopy using the National Cancer Institute Risk Assessment Tool.
    BMC Cancer. 2019;19:1097.
    >> Share

  216. LI JB, Luo S, Wong MCS, Li C, et al
    Longitudinal associations between BMI change and the risks of colorectal cancer incidence, cancer-relate and all-cause mortality among 81,388 older adults : BMI change and the risks of colorectal cancer incidence and mortality.
    BMC Cancer. 2019;19:1082.
    >> Share

  217. SHENG H, Wei X, Mao M, He J, et al
    Adenocarcinoma with mixed subtypes is a rare but aggressive histologic subtype in colorectal cancer.
    BMC Cancer. 2019;19:1071.
    >> Share

  218. KALMAR A, Nagy ZB, Galamb O, Csabai I, et al
    Genome-wide expression profiling in colorectal cancer focusing on lncRNAs in the adenoma-carcinoma transition.
    BMC Cancer. 2019;19:1059.
    >> Share

  219. AHIKO Y, Shida D, Horie T, Tanabe T, et al
    Controlling nutritional status (CONUT) score as a preoperative risk assessment index for older patients with colorectal cancer.
    BMC Cancer. 2019;19:946.
    >> Share

  220. STRICKLER JH, Rushing CN, Niedzwiecki D, McLeod A, et al
    A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancer.
    BMC Cancer. 2019;19:1032.
    >> Share

  221. MARTIN SZ, Wagner DC, Horner N, Horst D, et al
    Ex vivo tissue slice culture system to measure drug-response rates of hepatic metastatic colorectal cancer.
    BMC Cancer. 2019;19:1030.
    >> Share

  222. TROTSYUK I, Sparschuh H, Muller AJ, Neumann K, et al
    Tumor budding outperforms ypT and ypN classification in predicting outcome of rectal cancer after neoadjuvant chemoradiotherapy.
    BMC Cancer. 2019;19:1033.
    >> Share

    October 2019
  223. LI J, Kong XX, Zhou JJ, Song YM, et al
    Fast-track multidisciplinary treatment versus conventional treatment for colorectal cancer: a multicenter, open-label randomized controlled study.
    BMC Cancer. 2019;19:988.
    >> Share

  224. JOHANSEN AFB, Kassentoft CG, Knudsen M, Laursen MB, et al
    Validation of computational determination of microsatellite status using whole exome sequencing data from colorectal cancer patients.
    BMC Cancer. 2019;19:971.
    >> Share

  225. ADVANI SM, Advani PS, Brown DW, DeSantis SM, et al
    Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer.
    BMC Cancer. 2019;19:964.
    >> Share

  226. LI C, He X, Zhang L, Li L, et al
    A pair-wise meta-analysis highlights circular RNAs as potential biomarkers for colorectal cancer.
    BMC Cancer. 2019;19:957.
    >> Share

  227. YE SB, Cheng YK, Zhang L, Wang XP, et al
    Prognostic value of estrogen receptor-alpha and progesterone receptor in curatively resected colorectal cancer: a retrospective analysis with independent validations.
    BMC Cancer. 2019;19:933.
    >> Share

    September 2019
  228. MIZUSHIMA T, Ikeda M, Kato T, Ikeda A, et al
    Postoperative XELOX therapy for patients with curatively resected high-risk stage II and stage III rectal cancer without preoperative chemoradiation: a prospective, multicenter, open-label, single-arm phase II study.
    BMC Cancer. 2019;19:929.
    >> Share

  229. SAVOIE MB, Laffan A, Brickman C, Daniels B, et al
    A multi-disciplinary model of survivorship care following definitive chemoradiation for anal cancer.
    BMC Cancer. 2019;19:906.
    >> Share

  230. OTTAIANO A, Scala S, Normanno N, Napolitano M, et al
    Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol.
    BMC Cancer. 2019;19:899.
    >> Share

  231. HAGHI F, Goli E, Mirzaei B, Zeighami H, et al
    The association between fecal enterotoxigenic B. fragilis with colorectal cancer.
    BMC Cancer. 2019;19:879.
    >> Share

  232. CONRADI LC, Spitzner M, Metzger AL, Kisly M, et al
    Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer.
    BMC Cancer. 2019;19:880.
    >> Share

    August 2019
  233. AL-HUSSEINI MJ, Saad AM, Mohamed HH, Alkhayat MA, et al
    Impact of prior malignancies on outcome of colorectal cancer; revisiting clinical trial eligibility criteria.
    BMC Cancer. 2019;19:863.
    >> Share

  234. LI M, Olver I, Keefe D, Holden C, et al
    Pre-diagnostic colonoscopies reduce cancer mortality - results from linked population-based data in South Australia.
    BMC Cancer. 2019;19:856.
    >> Share

  235. ANTOUN S, Bayar MA, Dyevre V, Lanoy E, et al
    No evidence for changes in skeletal muscle mass or weight during first-line chemotherapy for metastatic colorectal cancer.
    BMC Cancer. 2019;19:847.
    >> Share

  236. LAWRANCE S, Bui C, Mahindra V, Arcorace M, et al
    Assessing a modified-AJCC TNM staging system in the New South Wales Cancer Registry, Australia.
    BMC Cancer. 2019;19:850.
    >> Share

  237. YOU Q, Fang Y, Li C, Tan Y, et al
    Multiple metastases of bones and sigmoid colon after mastectomy for ductal carcinoma in situ of the breast: a case report.
    BMC Cancer. 2019;19:844.
    >> Share

  238. WAN N, Weinberg D, Liu TY, Niehaus K, et al
    Machine learning enables detection of early-stage colorectal cancer by whole-genome sequencing of plasma cell-free DNA.
    BMC Cancer. 2019;19:832.
    >> Share

  239. LI H, Jin X, Liu B, Zhang P, et al
    CircRNA CBL.11 suppresses cell proliferation by sponging miR-6778-5p in colorectal cancer.
    BMC Cancer. 2019;19:826.
    >> Share

  240. PERILLI L, Tessarollo S, Albertoni L, Curtarello M, et al
    Silencing of miR-182 is associated with modulation of tumorigenesis through apoptosis induction in an experimental model of colorectal cancer.
    BMC Cancer. 2019;19:821.
    >> Share

  241. XIE X, Yin J, Zhou Z, Dang C, et al
    Young age increases the risk for lymph node metastasis in patients with early Colon Cancer.
    BMC Cancer. 2019;19:803.
    >> Share

  242. TANAKA T, Sato T, Nishiofuku H, Masada T, et al
    Selective TACE with irinotecan-loaded 40 mum microspheres and FOLFIRI for colorectal liver metastases: phase I dose escalation pharmacokinetic study.
    BMC Cancer. 2019;19:758.
    >> Share

    July 2019
  243. IMAIZUMI J, Shida D, Narita Y, Miyakita Y, et al
    Prognostic factors of brain metastases from colorectal cancer.
    BMC Cancer. 2019;19:755.
    >> Share

  244. DAPPER H, Schiller K, Munch S, Peeken JC, et al
    Have we achieved adequate recommendations for target volume definitions in anal cancer? A PET imaging based patterns of failure analysis in the context of established contouring guidelines.
    BMC Cancer. 2019;19:742.
    >> Share

  245. SARASQUETA C, Perales A, Escobar A, Bare M, et al
    Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer.
    BMC Cancer. 2019;19:735.
    >> Share

  246. FERNANDEZ-BANARES F, Cleries R, Boadas J, Ribes J, et al
    Prediction of advanced colonic neoplasm in symptomatic patients: a scoring system to prioritize colonoscopy (COLONOFIT study).
    BMC Cancer. 2019;19:734.
    >> Share

  247. TANABE T, Shida D, Komukai S, Nakamura Y, et al
    Long-term outcomes after surgical dissection of inguinal lymph node metastasis from rectal or anal canal adenocarcinoma.
    BMC Cancer. 2019;19:733.
    >> Share

  248. CHAKROBORTY D, Emani MR, Klen R, Bockelman C, et al
    L1TD1 - a prognostic marker for colon cancer.
    BMC Cancer. 2019;19:727.
    >> Share

  249. GEMOLL T, Miroll E, Klein O, Lischka A, et al
    Spatial UBE2N protein expression indicates genomic instability in colorectal cancers.
    BMC Cancer. 2019;19:710.
    >> Share

  250. GUAN X, Ma CX, Quan JC, Li S, et al
    A clinical model to predict the risk of synchronous bone metastasis in newly diagnosed colorectal cancer: a population-based study.
    BMC Cancer. 2019;19:704.
    >> Share

  251. BENCSIKOVA B, Budinska E, Selingerova I, Pilatova K, et al
    Circulating T cell subsets are associated with clinical outcome of anti-VEGF-based 1st-line treatment of metastatic colorectal cancer patients: a prospective study with focus on primary tumor sidedness.
    BMC Cancer. 2019;19:687.
    >> Share

  252. GAO Y, Nan X, Shi X, Mu X, et al
    SREBP1 promotes the invasion of colorectal cancer accompanied upregulation of MMP7 expression and NF-kappaB pathway activation.
    BMC Cancer. 2019;19:685.
    >> Share

  253. ALWERS E, Blaker H, Walter V, Jansen L, et al
    External validation of molecular subtype classifications of colorectal cancer based on microsatellite instability, CIMP, BRAF and KRAS.
    BMC Cancer. 2019;19:681.
    >> Share

  254. DUDANI S, Marginean H, Tang PA, Monzon JG, et al
    Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation.
    BMC Cancer. 2019;19:664.
    >> Share

  255. ADLARD KN, Jenkins DG, Salisbury CE, Bolam KA, et al
    Peer support for the maintenance of physical activity and health in cancer survivors: the PEER trial - a study protocol of a randomised controlled trial.
    BMC Cancer. 2019;19:656.
    >> Share

  256. NG TH, Sham KWY, Xie CM, Ng SSM, et al
    Eukaryotic elongation factor-2 kinase expression is an independent prognostic factor in colorectal cancer.
    BMC Cancer. 2019;19:649.
    >> Share

    June 2019
  257. CAVAGNARI MAV, Silva TD, Pereira MAH, Sauer LJ, et al
    Impact of genetic mutations and nutritional status on the survival of patients with colorectal cancer.
    BMC Cancer. 2019;19:644.
    >> Share

  258. CHEN SH, Tsai HL, Jiang JK, Sung YC, et al
    Emergence of RAS mutations in patients with metastatic colorectal cancer receiving cetuximab-based treatment: a study protocol.
    BMC Cancer. 2019;19:640.
    >> Share

  259. PETERSEN CH, Mahmood B, Badsted C, Dahlby T, et al
    Possible predisposition for colorectal carcinogenesis due to altered gene expressions in normal appearing mucosa from patients with colorectal neoplasia.
    BMC Cancer. 2019;19:643.
    >> Share

  260. TERAZAWA T, Kato T, Goto M, Sakai D, et al
    First-line single-agent panitumumab in frail elderly patients with wild-type RAS unresectable colorectal cancer: a phase II study protocol OGSG 1602.
    BMC Cancer. 2019;19:623.
    >> Share

  261. SONG Z, Chen E, Qian J, Xu J, et al
    Serum chitinase activity prognosticates metastasis of colorectal cancer.
    BMC Cancer. 2019;19:629.
    >> Share

  262. JIANG Y, Sun Y, Hu J, Yu N, et al
    A germline mutation in Rab43 gene identified from a cancer family predisposes to a hereditary liver-colon cancer syndrome.
    BMC Cancer. 2019;19:613.
    >> Share

  263. WANG H, Wang X, Xu L, Zhang J, et al
    Analysis of the transcriptomic features of microsatellite instability subtype colon cancer.
    BMC Cancer. 2019;19:605.
    >> Share

  264. FENG Y, Qian W, Zhang Y, Peng W, et al
    CDCA2 promotes the proliferation of colorectal cancer cells by activating the AKT/CCND1 pathway in vitro and in vivo.
    BMC Cancer. 2019;19:576.
    >> Share

  265. CALLEBOUT E, Ribeiro SM, Laurent S, De Man M, et al
    Long term response on Regorafenib in non-V600E BRAF mutated colon cancer: a case report.
    BMC Cancer. 2019;19:567.
    >> Share

  266. LEKOANE KMB, Kuupiel D, Mashamba-Thompson TP, Ginindza TG, et al
    Evidence on the prevalence, incidence, mortality and trends of human papilloma virus-associated cancers in sub-Saharan Africa: systematic scoping review.
    BMC Cancer. 2019;19:563.
    >> Share

  267. VRINTEN C, Gallagher A, Waller J, Marlow LAV, et al
    Cancer stigma and cancer screening attendance: a population based survey in England.
    BMC Cancer. 2019;19:566.
    >> Share

  268. CARRATO A, Benavides M, Massuti B, Ferreiro-Monteagudo R, et al
    First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD).
    BMC Cancer. 2019;19:533.
    >> Share

  269. SAIJO S, Kuwano Y, Tange S, Rokutan K, et al
    A novel long non-coding RNA from the HOXA6-HOXA5 locus facilitates colon cancer cell growth.
    BMC Cancer. 2019;19:532.
    >> Share

  270. TSAOUSIS GN, Papadopoulou E, Apessos A, Agiannitopoulos K, et al
    Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.
    BMC Cancer. 2019;19:535.
    >> Share

    May 2019
  271. ROQUETTE R, Painho M, Nunes B
    Geographical patterns of the incidence and mortality of colorectal cancer in mainland Portugal municipalities (2007-2011).
    BMC Cancer. 2019;19:512.
    >> Share

  272. CHEN Y, Yang X, Wen Z, Liu Y, et al
    Association between high-resolution MRI-detected extramural vascular invasion and tumour microcirculation estimated by dynamic contrast-enhanced MRI in rectal cancer: preliminary results.
    BMC Cancer. 2019;19:498.
    >> Share

  273. ABRAHAMSSON H, Porojnicu AC, Lindstrom JC, Dueland S, et al
    High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancer.
    BMC Cancer. 2019;19:488.
    >> Share

  274. KIM EG, Kim JO, Park HS, Ryu CS, et al
    Genetic associations between the miRNA polymorphisms miR-130b (rs373001), miR-200b (rs7549819), and miR-495 (rs2281611) and colorectal cancer susceptibility.
    BMC Cancer. 2019;19:480.
    >> Share

  275. WANG F, He MM, Wang ZX, Li S, et al
    Phase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with metastatic colorectal cancer or gastric cancer.
    BMC Cancer. 2019;19:460.
    >> Share

  276. BURM R, Thewes B, Rodwell L, Kievit W, et al
    Long-term efficacy and cost-effectiveness of blended cognitive behavior therapy for high fear of recurrence in breast, prostate and colorectal Cancer survivors: follow-up of the SWORD randomized controlled trial.
    BMC Cancer. 2019;19:462.
    >> Share

  277. CHEN Z, Wu G, Ye F, Chen G, et al
    High expression of MMP19 is associated with poor prognosis in patients with colorectal cancer.
    BMC Cancer. 2019;19:448.
    >> Share

  278. SUN J, Fei F, Zhang M, Li Y, et al
    The role of (m)SEPT9 in screening, diagnosis, and recurrence monitoring of colorectal cancer.
    BMC Cancer. 2019;19:450.
    >> Share

  279. PENNEY ME, Parfrey PS, Savas S, Yilmaz YE, et al
    Correction to: A genome-wide association study identifies single nucleotide polymorphisms associated with time-to-metastasis in colorectal cancer.
    BMC Cancer. 2019;19:437.
    >> Share

  280. NAKAGAWA-SENDA H, Hori M, Matsuda T, Ito H, et al
    Prognostic impact of tumor location in colon cancer: the Monitoring of Cancer Incidence in Japan (MCIJ) project.
    BMC Cancer. 2019;19:431.
    >> Share

  281. PRIETO SP, Reed CL, James HM, Quinn KP, et al
    Differences in colonic crypt morphology of spontaneous and colitis-associated murine models via second harmonic generation imaging to quantify colon cancer development.
    BMC Cancer. 2019;19:428.
    >> Share

  282. HENDRICKS A, Gieseler F, Nazzal S, Brasen JH, et al
    Prognostic relevance of topoisomerase II alpha and minichromosome maintenance protein 6 expression in colorectal cancer.
    BMC Cancer. 2019;19:429.
    >> Share

  283. LEE DW, Han SW, Cha Y, Bae JM, et al
    Association of pathway mutation with survival after recurrence in colorectal cancer patients treated with adjuvant fluoropyrimidine and oxaliplatin chemotherapy.
    BMC Cancer. 2019;19:421.
    >> Share

  284. HINES RB, Jiban MJH, Specogna AV, Vishnubhotla P, et al
    The association between post-treatment surveillance testing and survival in stage II and III colon cancer patients: An observational comparative effectiveness study.
    BMC Cancer. 2019;19:418.
    >> Share

    April 2019
  285. LEE JL, Lim SB, Yu CS, Park IJ, et al
    Local excision in mid-to-low rectal cancer patients who revealed clinically total or near-total regression after preoperative chemoradiotherapy; a proposed trial.
    BMC Cancer. 2019;19:404.
    >> Share

  286. BUNDGAARD-NIELSEN C, Baandrup UT, Nielsen LP, Sorensen S, et al
    The presence of bacteria varies between colorectal adenocarcinomas, precursor lesions and non-malignant tissue.
    BMC Cancer. 2019;19:399.
    >> Share

  287. ROVERS KP, Bakkers C, Simkens GAAM, Burger JWA, et al
    Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, ra
    BMC Cancer. 2019;19:390.
    >> Share

  288. DULSKAS A, Cereska V, Zurauskas E, Stratilatovas E, et al
    Prostate cancer solitary metastasis to anal canal: case report and review of literature.
    BMC Cancer. 2019;19:374.
    >> Share

  289. DE MESQUITA GHA, Carvalho BJ, de Almeida Medeiros KA, Nii F, et al
    Intussusception reveals MUTYH-associated polyposis syndrome and colorectal cancer: a case report.
    BMC Cancer. 2019;19:324.
    >> Share

  290. BUISMAN FE, Homs MYV, Grunhagen DJ, Filipe WF, et al
    Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.
    BMC Cancer. 2019;19:327.
    >> Share

  291. WU YY, Zhang X, Qin YY, Qin JQ, et al
    Mean platelet volume/platelet count ratio in colorectal cancer: a retrospective clinical study.
    BMC Cancer. 2019;19:314.
    >> Share

  292. ROTHE F, Maetens M, Rouas G, Paesmans M, et al
    CTCs as a prognostic and predictive biomarker for stage II/III Colon Cancer: a companion study to the PePiTA trial.
    BMC Cancer. 2019;19:304.
    >> Share

  293. GARCIA-TORRECILLAS JM, Olvera-Porcel MC, Ferrer-Marquez M, Rubio-Gil F, et al
    Spatial and temporal variations in Spain in the standardised ratio of in-hospital mortality due to colorectal cancer, 2008-2014.
    BMC Cancer. 2019;19:310.
    >> Share

  294. KIM E, Jung S, Park WS, Lee JH, et al
    Upregulation of SLC2A3 gene and prognosis in colorectal carcinoma: analysis of TCGA data.
    BMC Cancer. 2019;19:302.
    >> Share

    March 2019
  295. SANDBERG TP, Stuart MPME, Oosting J, Tollenaar RAEM, et al
    Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer.
    BMC Cancer. 2019;19:284.
    >> Share

  296. ZHENG B, Wang X, Wei M, Wang Q, et al
    First-line cetuximab versus bevacizumab for RAS and BRAF wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
    BMC Cancer. 2019;19:280.
    >> Share

  297. HARLE A, Guillet J, Thomas J, Demange J, et al
    HPV insertional pattern as a personalized tumor marker for the optimized tumor diagnosis and follow-up of patients with HPV-associated carcinomas: a case report.
    BMC Cancer. 2019;19:277.
    >> Share

  298. BOWLES EJA, Yu O, Ziebell R, Chen L, et al
    Cardiovascular medication use and risks of colon cancer recurrences and additional cancer events: a cohort study.
    BMC Cancer. 2019;19:270.
    >> Share

  299. HARADA K, Okamoto W, Mimaki S, Kawamoto Y, et al
    Comparative sequence analysis of patient-matched primary colorectal cancer, metastatic, and recurrent metastatic tumors after adjuvant FOLFOX chemotherapy.
    BMC Cancer. 2019;19:255.
    >> Share

  300. BASTIAENEN VP, Klaver CEL, Kok NFM, de Wilt JHW, et al
    Second and third look laparoscopy in pT4 colon cancer patients for early detection of peritoneal metastases; the COLOPEC 2 randomized multicentre trial.
    BMC Cancer. 2019;19:254.
    >> Share

  301. SHIBUTANI M, Maeda K, Nagahara H, Fukuoka T, et al
    The prognostic significance of the advanced lung cancer inflammation index in patients with unresectable metastatic colorectal cancer: a retrospective study.
    BMC Cancer. 2019;19:241.
    >> Share

  302. VAN BLARIGAN EL, Chan H, Van Loon K, Kenfield SA, et al
    Self-monitoring and reminder text messages to increase physical activity in colorectal cancer survivors (Smart Pace): a pilot randomized controlled trial.
    BMC Cancer. 2019;19:218.
    >> Share

  303. KAZLAUSKAS A, Darinskas A, Meskys R, Tamasauskas A, et al
    Isocytosine deaminase Vcz as a novel tool for the prodrug cancer therapy.
    BMC Cancer. 2019;19:197.
    >> Share

  304. HUMMEL S, Kohlmann W, Kollmeyer TM, Jenkins R, et al
    The contribution of the rs55705857 G allele to familial cancer risk as estimated in the Utah population database.
    BMC Cancer. 2019;19:190.
    >> Share

    February 2019
  305. JI H, Lu L, Huang J, Liu Y, et al
    IL1A polymorphisms is a risk factor for colorectal cancer in Chinese Han population: a case control study.
    BMC Cancer. 2019;19:181.
    >> Share

  306. TANABE T, Shida D, Tsukamoto S, Morizono G, et al
    Metachronous metastasis to inguinal lymph nodes from sigmoid colon adenocarcinoma with abdominal wall metastasis: a case report.
    BMC Cancer. 2019;19:180.
    >> Share

  307. KLEMENT RJ, Abbasi-Senger N, Adebahr S, Alheid H, et al
    The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases.
    BMC Cancer. 2019;19:173.
    >> Share

  308. WANG Y, Jiang T, Jiang M, Gu S, et al
    Appraising growth differentiation factor 15 as a promising biomarker in digestive system tumors: a meta-analysis.
    BMC Cancer. 2019;19:177.
    >> Share

  309. MJELLE R, Sjursen W, Thommesen L, Saetrom P, et al
    Small RNA expression from viruses, bacteria and human miRNAs in colon cancer tissue and its association with microsatellite instability and tumor location.
    BMC Cancer. 2019;19:161.
    >> Share

  310. CHEN M, Sharma A, Lin Y, Wu Y, et al
    Insluin and epithelial growth factor (EGF) promote programmed death ligand 1(PD-L1) production and transport in colon cancer stem cells.
    BMC Cancer. 2019;19:153.
    >> Share

  311. KHAN OF, Cusano E, Raissouni S, Pabia M, et al
    Immediate-term cognitive impairment following intravenous (IV) chemotherapy: a prospective pre-post design study.
    BMC Cancer. 2019;19:150.
    >> Share

  312. ERIKSEN AC, Sorensen FB, Lindebjerg J, Hager H, et al
    Programmed Death Ligand-1 expression in stage II colon cancer - experiences from a nationwide populationbased cohort.
    BMC Cancer. 2019;19:142.
    >> Share

  313. CHARETTE N, Vandeputte C, Ameye L, Bogaert CV, et al
    Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials.
    BMC Cancer. 2019;19:134.
    >> Share

  314. PENNEY ME, Parfrey PS, Savas S, Yilmaz YE, et al
    A genome-wide association study identifies single nucleotide polymorphisms associated with time-to-metastasis in colorectal cancer.
    BMC Cancer. 2019;19:133.
    >> Share

  315. LUO ZW, Zhu MG, Zhang ZQ, Ye FJ, et al
    Increased expression of Ki-67 is a poor prognostic marker for colorectal cancer patients: a meta analysis.
    BMC Cancer. 2019;19:123.
    >> Share

  316. SCHUURHUIZEN CSEW, Braamse AMJ, Konings IRHM, Verheul HMW, et al
    Predictors for use of psychosocial services in patients with metastatic colorectal cancer receiving first line systemic treatment.
    BMC Cancer. 2019;19:115.
    >> Share

    January 2019
  317. VAN ROOIJEN S, Carli F, Dalton S, Thomas G, et al
    Multimodal prehabilitation in colorectal cancer patients to improve functional capacity and reduce postoperative complications: the first international randomized controlled trial for multimodal prehabilitation.
    BMC Cancer. 2019;19:98.
    >> Share

  318. CASTELLANO-CASTILLO D, Morcillo S, Crujeiras AB, Sanchez-Alcoholado L, et al
    Association between serum 25-hydroxyvitamin D and global DNA methylation in visceral adipose tissue from colorectal cancer patients.
    BMC Cancer. 2019;19:93.
    >> Share

  319. LI B, Wang Y, Yin L, Huang G, et al
    Glucocorticoids promote the development of azoxymethane and dextran sulfate sodium-induced colorectal carcinoma in mice.
    BMC Cancer. 2019;19:94.
    >> Share

  320. CAI SR, Huang YQ, Zhang SZ, Li QL, et al
    Effects of subitems in the colorectal cancer screening protocol on the Chinese colorectal cancer screening program: an analysis based on natural community screening results.
    BMC Cancer. 2019;19:47.
    >> Share

  321. XIN H, Wang C, Liu Z
    miR-196a-5p promotes metastasis of colorectal cancer via targeting IkappaBalpha.
    BMC Cancer. 2019;19:30.
    >> Share

  322. CHANG J, Lin G, Ye M, Tong D, et al
    Decreased mean platelet volume predicts poor prognosis in metastatic colorectal cancer patients treated with first-line chemotherapy: results from mCRC biomarker study.
    BMC Cancer. 2019;19:15.
    >> Share

    December 2018
  323. TIAN P, Zhu Y, Zhang C, Guo X, et al
    Ras-ERK1/2 signaling contributes to the development of colorectal cancer via regulating H3K9ac.
    BMC Cancer. 2018;18:1286.
    >> Share

  324. XU Y, Yang X, Gao D, Yang L, et al
    Dihomo-gamma-linolenic acid inhibits xenograft tumor growth in mice bearing shRNA-transfected HCA-7 cells targeting delta-5-desaturase.
    BMC Cancer. 2018;18:1268.
    >> Share

  325. BARRESI V, Cinnirella G, Valenti G, Spampinato G, et al
    Gene expression profiles in genome instability-based classes of colorectal cancer.
    BMC Cancer. 2018;18:1265.
    >> Share

  326. LIN Z, Liu J, Peng L, Zhang D, et al
    Complete pathological response following neoadjuvant FOLFOX chemotherapy in BRCA2-mutant locally advanced rectal cancer: a case report.
    BMC Cancer. 2018;18:1253.
    >> Share

  327. LIU M, Sun W, Cai YY, Wu HZ, et al
    Validation of Quality of Life Instruments for Cancer Patients - Colorectal Cancer (QLICP-CR) in patients with colorectal cancer in Northeast China.
    BMC Cancer. 2018;18:1228.
    >> Share

  328. ALSHERIDAH N, Akhtar S
    Diet, obesity and colorectal carcinoma risk: results from a national cancer registry-based middle-eastern study.
    BMC Cancer. 2018;18:1227.
    >> Share

  329. DEN BAKKER CM, Schaafsma FG, Huirne JAF, Consten ECJ, et al
    Cancer survivors' needs during various treatment phases after multimodal treatment for colon cancer - is there a role for eHealth?
    BMC Cancer. 2018;18:1207.
    >> Share

  330. OYEYEMI SO, Braaten T, Licaj I, Lund E, et al
    Physical activity patterns and the risk of colorectal cancer in the Norwegian Women and Cancer study: a population-based prospective study.
    BMC Cancer. 2018;18:1216.
    >> Share

  331. PETRERA M, Paleari L, Clavarezza M, Puntoni M, et al
    The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 x 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients.
    BMC Cancer. 2018;18:1210.
    >> Share

  332. FORTEA-SANCHIS C, Martinez-Ramos D, Escrig-Sos J
    The lymph node status as a prognostic factor in colon cancer: comparative population study of classifications using the logarithm of the ratio between metastatic and nonmetastatic nodes (LODDS) versus the pN-TNM classification and ganglion ratio syste
    BMC Cancer. 2018;18:1208.
    >> Share

  333. JANG M, Kwon Y, Kim H, Kim H, et al
    Microsatellite instability test using peptide nucleic acid probe-mediated melting point analysis: a comparison study.
    BMC Cancer. 2018;18:1218.
    >> Share

  334. DIMITRIOU N, Felekouras E, Karavokyros I, Alexandrou A, et al
    Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
    BMC Cancer. 2018;18:1202.
    >> Share

    November 2018
  335. POMPSCH M, Vogel J, Classen F, Kranz P, et al
    The presumed MTH1-inhibitor TH588 sensitizes colorectal carcinoma cells to ionizing radiation in hypoxia.
    BMC Cancer. 2018;18:1190.
    >> Share

  336. RATJEN I, Schafmayer C, Enderle J, di Giuseppe R, et al
    Health-related quality of life in long-term survivors of colorectal cancer and its association with all-cause mortality: a German cohort study.
    BMC Cancer. 2018;18:1156.
    >> Share

  337. CHEN Y, Tan F, Wei L, Li X, et al
    Sleep duration and the risk of cancer: a systematic review and meta-analysis including dose-response relationship.
    BMC Cancer. 2018;18:1149.
    >> Share

  338. YAMAURA M, Yamada T, Watanabe R, Kawai H, et al
    Anal canal adenocarcinoma with neuroendocrine features accompanying secondary extramammary Paget disease, successfully treated with modified FOLFOX6: a case report.
    BMC Cancer. 2018;18:1142.
    >> Share

  339. HU H, Huang J, Lan P, Wang L, et al
    CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial.
    BMC Cancer. 2018;18:1145.
    >> Share

  340. KASPER S, Kisro J, Fuchs M, Muller C, et al
    Safety profile of trifluridine/tipiracil monotherapy in clinical practice: results of the German compassionate-use program for patients with metastatic colorectal cancer.
    BMC Cancer. 2018;18:1124.
    >> Share

  341. SHARAF LK, Sharma M, Chandel D, Shukla G, et al
    Prophylactic intervention of probiotics (L.acidophilus, L.rhamnosus GG) and celecoxib modulate Bax-mediated apoptosis in 1,2-dimethylhydrazine-induced experimental colon carcinogenesis.
    BMC Cancer. 2018;18:1111.
    >> Share

  342. WANG F, He W, Jiang C, Guo G, et al
    Prognostic value of inflammation-based scores in patients receiving radical resection for colorectal cancer.
    BMC Cancer. 2018;18:1102.
    >> Share

  343. LIU FR, Bai S, Feng Q, Pan XY, et al
    Anti-colorectal cancer effects of anti-p21Ras scFv delivered by the recombinant adenovirus KGHV500 and cytokine-induced killer cells.
    BMC Cancer. 2018;18:1087.
    >> Share

  344. BELLUCO C, Forlin M, Delrio P, Rega D, et al
    Elevated platelet count is a negative predictive and prognostic marker in locally advanced rectal cancer undergoing neoadjuvant chemoradiation: a retrospective multi-institutional study on 965 patients.
    BMC Cancer. 2018;18:1094.
    >> Share

  345. TIAN Y, Li J, Zhou T, Tong D, et al
    Spatially varying effects of predictors for the survival prediction of nonmetastatic colorectal Cancer.
    BMC Cancer. 2018;18:1084.
    >> Share

  346. YU P, Zhou M, Qu J, Fu L, et al
    The dynamic monitoring of CEA in response to chemotherapy and prognosis of mCRC patients.
    BMC Cancer. 2018;18:1076.
    >> Share

  347. ASHKTORAB H, Rahi H, Nouraie M, Shokrani B, et al
    GPNMB methylation: a new marker of potentially carcinogenic colon lesions.
    BMC Cancer. 2018;18:1068.
    >> Share

  348. NAGATA N, Nishijima T, Niikura R, Yokoyama T, et al
    Increased risk of non-AIDS-defining cancers in Asian HIV-infected patients: a long-term cohort study.
    BMC Cancer. 2018;18:1066.
    >> Share

  349. MAHMOOD S, English DR, MacInnis RJ, Karahalios A, et al
    Domain-specific physical activity and the risk of colorectal cancer: results from the Melbourne Collaborative Cohort Study.
    BMC Cancer. 2018;18:1063.
    >> Share

  350. LEE CH, Im EJ, Moon PG, Baek MC, et al
    Discovery of a diagnostic biomarker for colon cancer through proteomic profiling of small extracellular vesicles.
    BMC Cancer. 2018;18:1058.
    >> Share

  351. CRUZ-NOVA P, Schnoor M, Correa-Basurto J, Bello M, et al
    The small organic molecule C19 binds and strengthens the KRAS4b-PDEdelta complex and inhibits growth of colorectal cancer cells in vitro and in vivo.
    BMC Cancer. 2018;18:1056.
    >> Share

    October 2018
  352. KAERLEV L, Iachina M, Trosko O, Qvist N, et al
    Colon cancer patients with a serious psychiatric disorder present with a more advanced cancer stage and receive less adjuvant chemotherapy - A Nationwide Danish Cohort Study.
    BMC Cancer. 2018;18:1050.
    >> Share

  353. YE X, Mo M, Xu S, Yang Q, et al
    The hypermethylation of p16 gene exon 1 and exon 2: potential biomarkers for colorectal cancer and are associated with cancer pathological staging.
    BMC Cancer. 2018;18:1023.
    >> Share

  354. O'GORMAN C, Stack J, O'Ceilleachair A, Denieffe S, et al
    Colorectal cancer survivors: an investigation of symptom burden and influencing factors.
    BMC Cancer. 2018;18:1022.
    >> Share

  355. ZENG Z, Yang H, Xiao S
    ACTL6A expression promotes invasion, metastasis and epithelial mesenchymal transition of colon cancer.
    BMC Cancer. 2018;18:1020.
    >> Share

  356. PERTTULA K, Schiffman C, Edmands WMB, Petrick L, et al
    Untargeted lipidomic features associated with colorectal cancer in a prospective cohort.
    BMC Cancer. 2018;18:996.
    >> Share

  357. SPERLICH A, Balmert A, Doll D, Bauer S, et al
    Genetic and immunological biomarkers predict metastatic disease recurrence in stage III colon cancer.
    BMC Cancer. 2018;18:998.
    >> Share

  358. SHIGEMATSU Y, Inamura K, Yamamoto N, Mise Y, et al
    Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis.
    BMC Cancer. 2018;18:980.
    >> Share

  359. WANG X, Zamdborg L, Ye H, Grills IS, et al
    A matched-pair analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer versus early stage non-small cell lung cancer.
    BMC Cancer. 2018;18:962.
    >> Share

  360. SHI J, Fei J, Yi Q, Shen L, et al
    Treatment of colon cancer in a patient with systemic lupus erythematosus: a case report.
    BMC Cancer. 2018;18:961.
    >> Share

  361. DOTE S, Itakura S, Kamei K, Hira D, et al
    Oral mucositis associated with anti-EGFR therapy in colorectal cancer: single institutional retrospective cohort study.
    BMC Cancer. 2018;18:957.
    >> Share

  362. MIZOTA Y, Kanemitsu Y, Tsukamoto S, Shida D, et al
    ROK study-C (Rainbow of KIBOU study-colorectum): a colorectal cancer survivor cohort study on food, nutrition, physical activity, psychosocial factors and its influences on colorectal cancer recurrence, survival and quality of life in Japan.
    BMC Cancer. 2018;18:953.
    >> Share

  363. CANTERO-CID R, Casas-Martin J, Hernandez-Jimenez E, Cubillos-Zapata C, et al
    PD-L1/PD-1 crosstalk in colorectal cancer: are we targeting the right cells?
    BMC Cancer. 2018;18:945.
    >> Share

    September 2018
  364. YANG L, Xiong Z, Xie QK, He W, et al
    Second primary colorectal cancer after the initial primary colorectal cancer.
    BMC Cancer. 2018;18:931.
    >> Share

  365. DOS SANTOS JS, Bonafe GA, Pereira JA, Kanno DT, et al
    Rare perianal extramammary Paget disease successfully treated using topical Imiquimod therapy.
    BMC Cancer. 2018;18:921.
    >> Share

  366. TIKK K, Czock D, Haefeli WE, Kopp-Schneider A, et al
    Clinical trial protocol of the ASTER trial: a double-blind, randomized, placebo-controlled phase III trial evaluating the use of acetylsalicylic acid (ASA) for enhanced early detection of colorectal neoplasms.
    BMC Cancer. 2018;18:914.
    >> Share

  367. WHITE A, Ironmonger L, Steele RJC, Ormiston-Smith N, et al
    A review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK.
    BMC Cancer. 2018;18:906.
    >> Share

  368. LI N, Zhou W, Zhao L, Zhou J, et al
    Endometriosis-associated recto-sigmoid cancer: a case report.
    BMC Cancer. 2018;18:905.
    >> Share

  369. SEIDENSTICKER R, Damm R, Enge J, Seidensticker M, et al
    Local ablation or radioembolization of colorectal cancer metastases: comorbidities or older age do not affect overall survival.
    BMC Cancer. 2018;18:882.
    >> Share

  370. SCHLIEMANN D, Donnelly M, Dahlui M, Loh SY, et al
    The 'Be Cancer Alert Campaign': protocol to evaluate a mass media campaign to raise awareness about breast and colorectal cancer in Malaysia.
    BMC Cancer. 2018;18:881.
    >> Share

  371. MENDEZ LC, Hsieh E, Earle CC, Wong S, et al
    Synchronous anal canal carcinoma in a heterosexual couple.
    BMC Cancer. 2018;18:884.
    >> Share

  372. HO V, Chung L, Singh A, Lea V, et al
    Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis.
    BMC Cancer. 2018;18:869.
    >> Share

    August 2018
  373. DURINIKOVA E, Kozovska Z, Poturnajova M, Plava J, et al
    ALDH1A3 upregulation and spontaneous metastasis formation is associated with acquired chemoresistance in colorectal cancer cells.
    BMC Cancer. 2018;18:848.
    >> Share

  374. LUALDI M, Cavalleri A, Battaglia L, Colombo A, et al
    Early detection of colorectal adenocarcinoma: a clinical decision support tool based on plasma porphyrin accumulation and risk factors.
    BMC Cancer. 2018;18:841.
    >> Share

  375. SUN X, Ju T, Cummings RD
    Differential expression of Cosmc, T-synthase and mucins in Tn-positive colorectal cancers.
    BMC Cancer. 2018;18:827.
    >> Share

  376. SABER MM, Al-Mahallawi AM, Nassar NN, Stork B, et al
    Targeting colorectal cancer cell metabolism through development of cisplatin and metformin nano-cubosomes.
    BMC Cancer. 2018;18:822.
    >> Share

  377. PUIJK RS, Ruarus AH, Vroomen LGPH, van Tilborg AAJM, et al
    Colorectal liver metastases: surgery versus thermal ablation (COLLISION) - a phase III single-blind prospective randomized controlled trial.
    BMC Cancer. 2018;18:821.
    >> Share

  378. RUDERMAN S, Eshein A, Valuckaite V, Dougherty U, et al
    Early increase in blood supply (EIBS) is associated with tumor risk in the Azoxymethane model of colon cancer.
    BMC Cancer. 2018;18:814.
    >> Share

  379. TOSI D, Perez-Gracia E, Atis S, Vie N, et al
    Rational development of synergistic combinations of chemotherapy and molecular targeted agents for colorectal cancer treatment.
    BMC Cancer. 2018;18:812.
    >> Share

  380. LAN L, Liu H, Smith AR, Appelman C, et al
    Natural product derivative Gossypolone inhibits Musashi family of RNA-binding proteins.
    BMC Cancer. 2018;18:809.
    >> Share

  381. REDMOND HP, Neary PM, Jinih M, O'Connell E, et al
    RandomiSed clinical trial assessing Use of an anti-inflammatoRy aGent in attenUating peri-operatiVe inflAmmatioN in non-meTastatic colon cancer - the S.U.R.G.U.V.A.N.T. trial.
    BMC Cancer. 2018;18:794.
    >> Share

  382. LI N, Chen M, Cao Y, Li H, et al
    Bcl-2-associated athanogene 3(BAG3) is associated with tumor cell proliferation, migration, invasion and chemoresistance in colorectal cancer.
    BMC Cancer. 2018;18:793.
    >> Share

  383. GOERE D, Pignon JP, Gelli M, Elias D, et al
    Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
    BMC Cancer. 2018;18:787.
    >> Share

  384. KORDOWSKI F, Kolarova J, Schafmayer C, Buch S, et al
    Aberrant DNA methylation of ADAMTS16 in colorectal and other epithelial cancers.
    BMC Cancer. 2018;18:796.
    >> Share

    July 2018
  385. CHIU KWH, Lam KO, An H, Cheung GTC, et al
    Long-term outcomes and recurrence pattern of 18F-FDG PET-CT complete metabolic response in the first-line treatment of metastatic colorectal cancer: a lesion-based and patient-based analysis.
    BMC Cancer. 2018;18:776.
    >> Share

  386. MOGENSEN MB, Rossing M, Ostrup O, Larsen PN, et al
    Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing.
    BMC Cancer. 2018;18:752.
    >> Share

  387. LEERMAKERS L, Doking S, Thewes B, Braamse AMJ, et al
    Study protocol of the CORRECT multicenter trial: the efficacy of blended cognitive behavioral therapy for reducing psychological distress in colorectal cancer survivors.
    BMC Cancer. 2018;18:748.
    >> Share

  388. TIKK K, Weigl K, Hoffmeister M, Igel S, et al
    Study protocol of the RaPS study: novel risk adapted prevention strategies for people with a family history of colorectal cancer.
    BMC Cancer. 2018;18:720.
    >> Share

    June 2018
  389. MOLNAR B, Galamb O, Peterfia B, Wichmann B, et al
    Gene promoter and exon DNA methylation changes in colon cancer development - mRNA expression and tumor mutation alterations.
    BMC Cancer. 2018;18:695.
    >> Share

  390. YOUNG EL, Thompson BA, Neklason DW, Firpo MA, et al
    Pancreatic cancer as a sentinel for hereditary cancer predisposition.
    BMC Cancer. 2018;18:697.
    >> Share

  391. CRESPO A, Garcia-Suarez O, Fernandez-Vega I, Solis-Hernandez MP, et al
    Heparan sulfate proteoglycans undergo differential expression alterations in left sided colorectal cancer, depending on their metastatic character.
    BMC Cancer. 2018;18:687.
    >> Share

  392. BOCKELMAN C, Beilmann-Lehtonen I, Kaprio T, Koskensalo S, et al
    Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer.
    BMC Cancer. 2018;18:679.
    >> Share

  393. NEILSEN BK, Chakraborty B, McCall JL, Frodyma DE, et al
    WDR5 supports colon cancer cells by promoting methylation of H3K4 and suppressing DNA damage.
    BMC Cancer. 2018;18:673.
    >> Share

  394. KOZOVSKA Z, Patsalias A, Bajzik V, Durinikova E, et al
    ALDH1A inhibition sensitizes colon cancer cells to chemotherapy.
    BMC Cancer. 2018;18:656.
    >> Share

  395. PANATO C, Abusamaan K, Bidoli E, Hamdi-Cherif M, et al
    Survival after the diagnosis of breast or colorectal cancer in the GAZA Strip from 2005 to 2014.
    BMC Cancer. 2018;18:632.
    >> Share

  396. GUAN X, Wang Y, Hu H, Zhao Z, et al
    Reconsideration of the optimal minimum lymph node count for young colon cancer patients: a population-based study.
    BMC Cancer. 2018;18:623.
    >> Share

    May 2018
  397. VANIA L, Rebelo TM, Ferreira E, Weiss SFT, et al
    Knock-down of LRP/LR promotes apoptosis in early and late stage colorectal carcinoma cells via caspase activation.
    BMC Cancer. 2018;18:602.
    >> Share

  398. KIM SC, Shin YK, Kim YA, Jang SG, et al
    Identification of genes inducing resistance to ionizing radiation in human rectal cancer cell lines: re-sensitization of radio-resistant rectal cancer cells through down regulating NDRG1.
    BMC Cancer. 2018;18:594.
    >> Share

  399. GONG X, Chen Z, Han Q, Chen C, et al
    Sanguinarine triggers intrinsic apoptosis to suppress colorectal cancer growth through disassociation between STRAP and MELK.
    BMC Cancer. 2018;18:578.
    >> Share

  400. PRICOLO VE, Bonvini M, Abelli CF
    Patterns of care for anal cancer in the United States - a comparison between academic and community cancer centers.
    BMC Cancer. 2018;18:567.
    >> Share

  401. YANG L, Xiong Z, Xie Q, He W, et al
    Prognostic value of total number of lymph nodes retrieved differs between left-sided colon cancer and right-sided colon cancer in stage III patients with colon cancer.
    BMC Cancer. 2018;18:558.
    >> Share

  402. DE-MASI A, Davis E, Cuming T, Chindawi N, et al
    The acceptability of high resolution anoscopy examination in patients attending a tertiary referral centre.
    BMC Cancer. 2018;18:554.
    >> Share

  403. SHULDINER J, Liu Y, Lofters A
    Incidence of breast and colorectal cancer among immigrants in Ontario, Canada: a retrospective cohort study from 2004-2014.
    BMC Cancer. 2018;18:537.
    >> Share

  404. KIM CW, Kang BM, Kim IY, Kim JY, et al
    Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
    BMC Cancer. 2018;18:538.
    >> Share

  405. RUHL R, Rana S, Kelley K, Espinosa-Diez C, et al
    microRNA-451a regulates colorectal cancer proliferation in response to radiation.
    BMC Cancer. 2018;18:517.
    >> Share

  406. REYNOLDS LM, Bissett IP, Consedine NS
    Emotional predictors of bowel screening: the avoidance-promoting role of fear, embarrassment, and disgust.
    BMC Cancer. 2018;18:518.
    >> Share

  407. DI GIROLAMO C, Walters S, Benitez Majano S, Rachet B, et al
    Characteristics of patients with missing information on stage: a population-based study of patients diagnosed with colon, lung or breast cancer in England in 2013.
    BMC Cancer. 2018;18:492.
    >> Share

  408. LILES EG, Perrin N, Rosales AG, Smith DH, et al
    Performance of a quantitative fecal immunochemical test for detecting advanced colorectal neoplasia: a prospective cohort study.
    BMC Cancer. 2018;18:509.
    >> Share

    April 2018
  409. MEI Z, Shao YW, Lin P, Cai X, et al
    SMAD4 and NF1 mutations as potential biomarkers for poor prognosis to cetuximab-based therapy in Chinese metastatic colorectal cancer patients.
    BMC Cancer. 2018;18:479.
    >> Share

  410. FORSTER I, Brockmann M, Schildgen O, Schildgen V, et al
    Microsatellite instability testing in colorectal cancer using the QiaXcel advanced platform.
    BMC Cancer. 2018;18:484.
    >> Share

  411. HEALY MA, Morris AM, Abrahamse P, Ward KC, et al
    The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry program.
    BMC Cancer. 2018;18:481.
    >> Share

  412. ZICHI C, Tampellini M, Tucci M, Sonetto C, et al
    FOLFOX activity in a rare case of metastatic colonic adenocarcinoma of the tongue: a case report.
    BMC Cancer. 2018;18:470.
    >> Share

  413. BRONZWAER MES, Greuter MJE, Bleijenberg AGC, IJspeert JEG, et al
    Impact of differences in adenoma and proximal serrated polyp detection rate on the long-term effectiveness of FIT-based colorectal cancer screening.
    BMC Cancer. 2018;18:465.
    >> Share

  414. ARROSPIDE A, Idigoras I, Mar J, de Koning H, et al
    Cost-effectiveness and budget impact analyses of a colorectal cancer screening programme in a high adenoma prevalence scenario using MISCAN-Colon microsimulation model.
    BMC Cancer. 2018;18:464.
    >> Share

  415. MUNKER S, Gerken M, Fest P, Ott C, et al
    Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects.
    BMC Cancer. 2018;18:455.
    >> Share

  416. MENG H, Li W, Boardman LA, Wang L, et al
    Loss of ZG16 is associated with molecular and clinicopathological phenotypes of colorectal cancer.
    BMC Cancer. 2018;18:433.
    >> Share

  417. FANG HJ, Shan SB, Zhou YH, Zhong LY, et al
    Diabetes mellitus and the risk of gastrointestinal cancer in women compared with men: a meta-analysis of cohort studies.
    BMC Cancer. 2018;18:422.
    >> Share

  418. GAUTHE M, Richard-Molard M, Rigault E, Buecher B, et al
    Prognostic value of serum CYFRA 21-1 1 in patients with anal canal squamous cell carcinoma treated with radio(chemo)therapy.
    BMC Cancer. 2018;18:417.
    >> Share

  419. SHINOZAKI E, Tanabe K, Akiyoshi T, Tsuchida T, et al
    Serum leucine-rich alpha-2-glycoprotein-1 with fucosylated triantennary N-glycan: a novel colorectal cancer marker.
    BMC Cancer. 2018;18:406.
    >> Share

  420. SORIANO LC, Soriano-Gabarro M, Garcia Rodriguez LA
    Trends in the contemporary incidence of colorectal cancer and patient characteristics in the United Kingdom: a population-based cohort study using The Health Improvement Network.
    BMC Cancer. 2018;18:402.
    >> Share

  421. DA COSTA PLN, Wynne D, Fifis T, Nguyen L, et al
    The kallikrein-Kinin system modulates the progression of colorectal liver metastases in a mouse model.
    BMC Cancer. 2018;18:382.
    >> Share

  422. WANG H, Chen X, Liu H, Mou T, et al
    Laparoscopy-assisted colectomy as an Oncologically safe alternative for patients with stage T4 Colon Cancer: a propensity-matched cohort study.
    BMC Cancer. 2018;18:370.
    >> Share

  423. SHIBUTANI M, Maeda K, Nagahara H, Fukuoka T, et al
    A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study.
    BMC Cancer. 2018;18:371.
    >> Share

  424. SANDRA-PETRESCU F, Herrle F, Burkholder I, Kienle P, et al
    Influence of complete administration of adjuvant chemotherapy cycles on overall and disease-free survival in locally advanced rectal cancer: post hoc analysis of a randomized, multicenter, non-inferiority, phase 3 trial.
    BMC Cancer. 2018;18:369.
    >> Share

  425. SHIN HY, Suh M, Choi KS, Hwang SH, et al
    Higher satisfaction with an alternative collection device for stool sampling in colorectal cancer screening with fecal immunochemical test: a cross-sectional study.
    BMC Cancer. 2018;18:365.
    >> Share

  426. SHEN MH, Chen LP, Ho TF, Shih YY, et al
    Validation of the Taiwan Chinese version of the EORTC QLQ-CR29 to assess quality of life in colorectal cancer patients.
    BMC Cancer. 2018;18:353.
    >> Share

    March 2018
  427. SHIDA D, Ahiko Y, Tanabe T, Yoshida T, et al
    Shorter survival in adolescent and young adult patients, compared to adult patients, with stage IV colorectal cancer in Japan.
    BMC Cancer. 2018;18:334.
    >> Share

  428. HAMASHIMA C, Sano H
    Association between age factors and strategies for promoting participation in gastric and colorectal cancer screenings.
    BMC Cancer. 2018;18:345.
    >> Share

  429. YOUNG JM, Durcinoska I, DeLoyde K, Solomon MJ, et al
    Patterns of follow up and survivorship care for people with colorectal cancer in new South Wales, Australia: a population-based survey.
    BMC Cancer. 2018;18:339.
    >> Share

  430. HUANG EY, Chang JC, Chen HH, Hsu CY, et al
    Carcinoembryonic antigen as a marker of radioresistance in colorectal cancer: a potential role of macrophages.
    BMC Cancer. 2018;18:321.
    >> Share

  431. BUROCK S, Daum S, Keilholz U, Neumann K, et al
    Phase II trial to investigate the safety and efficacy of orally applied niclosamide in patients with metachronous or sychronous metastases of a colorectal cancer progressing after therapy: the NIKOLO trial.
    BMC Cancer. 2018;18:297.
    >> Share

  432. TAI LH, Ananth AA, Seth R, Alkayyal A, et al
    Sepsis increases perioperative metastases in a murine model.
    BMC Cancer. 2018;18:277.
    >> Share

  433. GAO P, Huang XZ, Song YX, Sun JX, et al
    Impact of timing of adjuvant chemotherapy on survival in stage III colon cancer: a population-based study.
    BMC Cancer. 2018;18:234.
    >> Share

  434. EL KINANY K, Deoula M, Hatime Z, Bennani B, et al
    Dairy products and colorectal cancer in middle eastern and north African countries: a systematic review.
    BMC Cancer. 2018;18:233.
    >> Share

    February 2018
  435. GRAY RT, Coleman HG, Hughes C, Murray LJ, et al
    Low-dose aspirin use and survival in colorectal cancer: results from a population-based cohort study.
    BMC Cancer. 2018;18:228.
    >> Share

  436. STRAINIENE E, Binkis M, Urnikyte S, Stankevicius V, et al
    Microenvironment dependent gene expression signatures in reprogrammed human colon normal and cancer cell lines.
    BMC Cancer. 2018;18:222.
    >> Share

  437. KOWALCZYK M, Orlowski M, Siermontowski P, Mucha D, et al
    Occurrence of colorectal aberrant crypt foci depending on age and dietary patterns of patients.
    BMC Cancer. 2018;18:213.
    >> Share

  438. WANG T, Ning K, Sun X, Zhang C, et al
    Glycolysis is essential for chemoresistance induced by transient receptor potential channel C5 in colorectal cancer.
    BMC Cancer. 2018;18:207.
    >> Share

  439. HEUBLEIN S, Albertsmeier M, Pfeifer D, Loehrs L, et al
    Association of differential miRNA expression with hepatic vs. peritoneal metastatic spread in colorectal cancer.
    BMC Cancer. 2018;18:201.
    >> Share

  440. ARJONA-SANCHEZ A, Barrios P, Boldo-Roda E, Camps B, et al
    HIPECT4: multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma.
    BMC Cancer. 2018;18:183.
    >> Share

  441. ZHU Y, Wang PP, Zhai G, Bapat B, et al
    Association of rs2282679 A>C polymorphism in vitamin D binding protein gene with colorectal cancer risk and survival: effect modification by dietary vitamin D intake.
    BMC Cancer. 2018;18:155.
    >> Share

  442. RICHTER J, Kretz AL, Lemke J, Fauler M, et al
    CK1alpha overexpression correlates with poor survival in colorectal cancer.
    BMC Cancer. 2018;18:140.
    >> Share

  443. MARTINEZ-USEROS J, Moreno I, Fernandez-Acenero MJ, Rodriguez-Remirez M, et al
    The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.
    BMC Cancer. 2018;18:144.
    >> Share

  444. KLAUCK PJ, Bagby SM, Capasso A, Bradshaw-Pierce EL, et al
    Antitumor activity of the polo-like kinase inhibitor, TAK-960, against preclinical models of colorectal cancer.
    BMC Cancer. 2018;18:136.
    >> Share

  445. OZAKI Y, Shindoh J, Gonoi W, Nishioka Y, et al
    Changes in CT morphology can be an independent response marker for patients receiving regorafenib for colorectal liver metastases: retrospective pilot study.
    BMC Cancer. 2018;18:138.
    >> Share

    January 2018
  446. BATTAGLIN F, Schirripa M, Buggin F, Pietrantonio F, et al
    The PANDA study: a randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients.
    BMC Cancer. 2018;18:98.
    >> Share

  447. BUSCH EL, Don PK, Chu H, Richardson DB, et al
    Diagnostic accuracy and prediction increment of markers of epithelial-mesenchymal transition to assess cancer cell detachment from primary tumors.
    BMC Cancer. 2018;18:82.
    >> Share

  448. ENGSTRAND J, Nilsson H, Stromberg C, Jonas E, et al
    Colorectal cancer liver metastases - a population-based study on incidence, management and survival.
    BMC Cancer. 2018;18:78.
    >> Share

  449. WANG X, Chen J, Wang J, Yu F, et al
    Correction to: Metalloproteases meprin-a (MEP1A) is a prognostic biomarker and promotes proliferation and invasion of colorectal cancer.
    BMC Cancer. 2018;18:70.
    >> Share

  450. SHAW E, Farris MS, Stone CR, Derksen JWG, et al
    Effects of physical activity on colorectal cancer risk among family history and body mass index subgroups: a systematic review and meta-analysis.
    BMC Cancer. 2018;18:71.
    >> Share

  451. KONG X, Li J, Cai Y, Tian Y, et al
    A modified TNM staging system for non-metastatic colorectal cancer based on nomogram analysis of SEER database.
    BMC Cancer. 2018;18:50.
    >> Share

  452. DAVIS MM, Freeman M, Shannon J, Coronado GD, et al
    A systematic review of clinic and community intervention to increase fecal testing for colorectal cancer in rural and low-income populations in the United States - How, what and when?
    BMC Cancer. 2018;18:40.
    >> Share

  453. HERNANDEZ RK, Wade SW, Reich A, Pirolli M, et al
    Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States.
    BMC Cancer. 2018;18:44.
    >> Share

  454. GU MJ, Huang QC, Bao CZ, Li YJ, et al
    Attributable causes of colorectal cancer in China.
    BMC Cancer. 2018;18:38.
    >> Share

  455. FENNELL LJ, Jamieson S, McKeone D, Corish T, et al
    MLH1-93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAF(V600E) mutation.
    BMC Cancer. 2018;18:35.
    >> Share

  456. DEPCZYNSKI J, Dobbins T, Armstrong B, Lower T, et al
    Comparison of cancer incidence in Australian farm residents 45 years and over, compared to rural non-farm and urban residents - a data linkage study.
    BMC Cancer. 2018;18:33.
    >> Share

  457. FARSHIDFAR F, Kopciuk KA, Hilsden R, McGregor SE, et al
    A quantitative multimodal metabolomic assay for colorectal cancer.
    BMC Cancer. 2018;18:26.
    >> Share

  458. ARAKAWA K, Hata K, Yamamoto Y, Nishikawa T, et al
    Nine primary malignant neoplasms-involving the esophagus, stomach, colon, rectum, prostate, and external ear canal-without microsatellite instability: a case report.
    BMC Cancer. 2018;18:24.
    >> Share

  459. HUEMER F, Thaler J, Piringer G, Hackl H, et al
    Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentose Tumortherapie).
    BMC Cancer. 2018;18:11.
    >> Share

    December 2017
  460. ZHANG K, Wang Y, Yu X, Shi Y, et al
    Recombinant human endostatin combined with radiotherapy inhibits colorectal cancer growth.
    BMC Cancer. 2017;17:899.
    >> Share

  461. FALKOWSKI S, Woillard JB, Postil D, Tubiana-Mathieu N, et al
    Common variants in glucuronidation enzymes and membrane transporters as potential risk factors for colorectal cancer: a case control study.
    BMC Cancer. 2017;17:901.
    >> Share

  462. SONG N, Shin A, Jung HS, Oh JH, et al
    Effects of interactions between common genetic variants and smoking on colorectal cancer.
    BMC Cancer. 2017;17:869.
    >> Share

  463. SHIN HY, Suh M, Park B, Jun JK, et al
    Perceptions of colorectal cancer screening and recommendation behaviors among physicians in Korea.
    BMC Cancer. 2017;17:860.
    >> Share

  464. YEH YS, Chang YT, Ma CJ, Huang CW, et al
    First-decade patient with colorectal cancer carrying both germline and somatic mutations in APC gene.
    BMC Cancer. 2017;17:849.
    >> Share

  465. CAO B, Luo L, Feng L, Ma S, et al
    A network-based predictive gene-expression signature for adjuvant chemotherapy benefit in stage II colorectal cancer.
    BMC Cancer. 2017;17:844.
    >> Share

  466. BEEBE-DIMMER JL, Yee C, Paskett E, Schwartz AG, et al
    Family history of prostate and colorectal cancer and risk of colorectal cancer in the Women's health initiative.
    BMC Cancer. 2017;17:848.
    >> Share

  467. LEE J, Xiao YY, Sun YY, Balderacchi J, et al
    Prevalence and characteristics of hereditary non-polyposis colorectal cancer (HNPCC) syndrome in immigrant Asian colorectal cancer patients.
    BMC Cancer. 2017;17:843.
    >> Share

  468. VULCAN A, Manjer J, Ohlsson B
    High blood glucose levels are associated with higher risk of colon cancer in men: a cohort study.
    BMC Cancer. 2017;17:842.
    >> Share

  469. COELHO H, Jones-Hughes T, Snowsill T, Briscoe S, et al
    A systematic review of test accuracy studies evaluating molecular micro-satellite instability testing for the detection of individuals with lynch syndrome.
    BMC Cancer. 2017;17:836.
    >> Share

  470. BENEDICTO A, Marquez J, Herrero A, Olaso E, et al
    Decreased expression of the beta2 integrin on tumor cells is associated with a reduction in liver metastasis of colorectal cancer in mice.
    BMC Cancer. 2017;17:827.
    >> Share

  471. ZHOU P, Wang C, Hu Z, Chen W, et al
    Genistein induces apoptosis of colon cancer cells by reversal of epithelial-to-mesenchymal via a Notch1/NF-kappaB/slug/E-cadherin pathway.
    BMC Cancer. 2017;17:813.
    >> Share

    November 2017
  472. HAN VAN KRIEKEN J, Kafatos G, Bennett J, Mineur L, et al
    Panitumumab use in metastatic colorectal cancer and patterns of RAS testing: results from a Europe-wide physician survey and medical records review.
    BMC Cancer. 2017;17:798.
    >> Share

  473. YANG J, Du XL, Li S, Wu Y, et al
    The risk and survival outcome of subsequent primary colorectal cancer after the first primary colorectal cancer: cases from 1973 to 2012.
    BMC Cancer. 2017;17:783.
    >> Share

  474. THIEBAULT Q, Defossez G, Karayan-Tapon L, Ingrand P, et al
    Analysis of factors influencing molecular testing at diagnostic of colorectal cancer.
    BMC Cancer. 2017;17:765.
    >> Share

  475. STEVANATO FILHO PR, Aguiar Junior S, Begnami MD, Kuasne H, et al
    Oestrogen receptor beta isoform expression in sporadic colorectal cancer, familial adenomatous polyposis and progressive stages of colorectal cancer.
    BMC Cancer. 2017;17:754.
    >> Share

  476. SONG Y, Yang Y, Gao P, Chen X, et al
    The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer.
    BMC Cancer. 2017;17:744.
    >> Share

  477. ALONSO-MOLERO J, Gonzalez-Donquiles C, Fernandez-Villa T, de Souza-Teixeira F, et al
    Alterations in PGC1alpha expression levels are involved in colorectal cancer risk: a qualitative systematic review.
    BMC Cancer. 2017;17:731.
    >> Share

  478. ERNST J, Mehnert A, Dietz A, Hornemann B, et al
    Perceived stigmatization and its impact on quality of life - results from a large register-based study including breast, colon, prostate and lung cancer patients.
    BMC Cancer. 2017;17:741.
    >> Share

  479. TAKAHASHI H, Takahashi M, Ohnuma S, Unno M, et al
    microRNA-193a-3p is specifically down-regulated and acts as a tumor suppressor in BRAF-mutated colorectal cancer.
    BMC Cancer. 2017;17:723.
    >> Share

  480. YANG C, Zou K, Zheng L, Xiong B, et al
    Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
    BMC Cancer. 2017;17:725.
    >> Share

  481. YU X, Mi L, Dong J, Zou J, et al
    Long intergenic non-protein-coding RNA 1567 (LINC01567) acts as a "sponge" against microRNA-93 in regulating the proliferation and tumorigenesis of human colon cancer stem cells.
    BMC Cancer. 2017;17:716.
    >> Share

    October 2017
  482. STEVENS JR, Herrick JS, Wolff RK, Slattery ML, et al
    Identifying factors associated with the direction and significance of microRNA tumor-normal expression differences in colorectal cancer.
    BMC Cancer. 2017;17:707.
    >> Share

  483. RATJEN I, Schafmayer C, di Giuseppe R, Waniek S, et al
    Postdiagnostic physical activity, sleep duration, and TV watching and all-cause mortality among long-term colorectal cancer survivors: a prospective cohort study.
    BMC Cancer. 2017;17:701.
    >> Share

  484. UNGARI AQ, Pereira LRL, Nunes AA, Peria FM, et al
    Cost-effectiveness analysis of XELOX versus XELOX plus bevacizumab for metastatic colorectal cancer in a public hospital school.
    BMC Cancer. 2017;17:691.
    >> Share

    August 2017
  485. PARK SM, Lee J, Kim YA, Chang YJ, et al
    Factors related with colorectal and stomach cancer screening practice among disease-free lung cancer survivors in Korea.
    BMC Cancer. 2017;17:600.
    >> Share

    June 2017
  486. COEN M, Rigamonti F, Roth A, Koessler T, et al
    Chemotherapy-induced Takotsubo cardiomyopathy, a case report and review of the literature.
    BMC Cancer. 2017;17:394.
    >> Share

    May 2017
  487. DARWANTO A, Hein AM, Strauss S, Kong Y, et al
    Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform.
    BMC Cancer. 2017;17:358.
    >> Share

  488. DE FELICE F, Benevento I, Magnante AL, Musio D, et al
    Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis : Oxaliplatin in neoadjuvant treatment for rectal cancer.
    BMC Cancer. 2017;17:325.
    >> Share

    April 2017
  489. LELONG B, de Chaisemartin C, Meillat H, Cournier S, et al
    A multicentre randomised controlled trial to evaluate the efficacy, morbidity and functional outcome of endoscopic transanal proctectomy versus laparoscopic proctectomy for low-lying rectal cancer (ETAP-GRECCAR 11 TRIAL): rationale and design.
    BMC Cancer. 2017;17:253.
    >> Share

    March 2017
  490. LI X, Lu H, Xu K, Wang H, et al
    Negative lymph node count is an independent prognostic factor for patients with rectal cancer who received preoperative radiotherapy.
    BMC Cancer. 2017;17:227.
    >> Share

  491. BERNTSEN S, Aaronson NK, Buffart L, Borjeson S, et al
    Design of a randomized controlled trial of physical training and cancer (Phys-Can) - the impact of exercise intensity on cancer related fatigue, quality of life and disease outcome.
    BMC Cancer. 2017;17:218.
    >> Share

  492. CERVANTES-MADRID D, Wettergren Y, Falk P, Lundholm K, et al
    DNA alterations in Cd133+ and Cd133- tumour cells enriched from intra-operative human colon tumour biopsies.
    BMC Cancer. 2017;17:219.
    >> Share

  493. FENG YR, Jin J, Ren H, Wang X, et al
    Patients with pathological stage N2 rectal cancer treated with early adjuvant chemotherapy have a lower treatment failure rate.
    BMC Cancer. 2017;17:182.
    >> Share

  494. FORZATI F, De Martino M, Esposito F, Sepe R, et al
    miR-155 is positively regulated by CBX7 in mouse embryonic fibroblasts and colon carcinomas, and targets the KRAS oncogene.
    BMC Cancer. 2017;17:170.
    >> Share

    February 2017
  495. BRUNET J, Burke S, Grocott MP, West MA, et al
    The effects of exercise on pain, fatigue, insomnia, and health perceptions in patients with operable advanced stage rectal cancer prior to surgery: a pilot trial.
    BMC Cancer. 2017;17:153.
    >> Share

  496. SINGH VP, Katta S, Kumar S
    WD-repeat protein WDR13 is a novel transcriptional regulator of c-Jun and modulates intestinal homeostasis in mice.
    BMC Cancer. 2017;17:148.
    >> Share

  497. WEYN C, Van Raemdonck S, Dendooven R, Maes V, et al
    Clinical performance evaluation of a sensitive, rapid low-throughput test for KRAS mutation analysis using formalin-fixed, paraffin-embedded tissue samples.
    BMC Cancer. 2017;17:139.
    >> Share

  498. PAHLE J, Menzel L, Niesler N, Kobelt D, et al
    Rapid eradication of colon carcinoma by Clostridium perfringens Enterotoxin suicidal gene therapy.
    BMC Cancer. 2017;17:129.
    >> Share

  499. MEDENWALD D, Vordermark D, Dietzel CT
    Cancer mortality in former East and West Germany: a story of unification?
    BMC Cancer. 2017;17:94.
    >> Share

    January 2017
  500. STEVENSON HL, Prats MM, Sasatomi E
    Chemotherapy-induced Sinusoidal Injury (CSI) score: a novel histologic assessment of chemotherapy-related hepatic sinusoidal injury in patients with colorectal liver metastasis.
    BMC Cancer. 2017;17:35.
    >> Share

    December 2016
  501. YEDID N, Kalma Y, Malcov M, Amit A, et al
    The effect of a germline mutation in the APC gene on beta-catenin in human embryonic stem cells.
    BMC Cancer. 2016;16:952.
    >> Share

    November 2016
  502. ZHANG J, Ren J, Wei J, Chong CC, et al
    Alternative splicing of estrogen receptor alpha in hepatocellular carcinoma.
    BMC Cancer. 2016;16:926.
    >> Share

  503. STEPPELER C, Sodring M, Paulsen JE
    Colorectal Carcinogenesis in the A/J Min/+ Mouse Model is Inhibited by Hemin, Independently of Dietary Fat Content and Fecal Lipid Peroxidation Rate.
    BMC Cancer. 2016;16:832.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016